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Abstract 
 
Background: Over-the-counter medications are widely used by the Palestinian population, 
including pregnancy women. This study seeks to find out the prevalence of use OTC 
medications by pregnant women, and the effects of these drugs on their pregnancy. The 
objectives of the study are concluded in finding out the level of using OTC medications 
among pregnant women, and the awareness of the effects of such drugs on the women and 
their babies. This study has been motivated by the fact that taking of over the counter 
medicines has in some cases resulted in the birth of deformed babies among other 
challenges health and physical challenges. 
 
Methods: The study has employed a descriptive design. The population of the pregnant 
women will act as the target population. The sampling process was stratified by site and 
the researcher interviewed 555 pregnant women as target sample. Data were collected by 
interviewing the pregnant women in three main governate hospitals, in Nablus (North), 
Ramallah (Center), Hebron (South) and in private clinics and hospitals. These women 
filled out questionnaires to determine the prevalence of using OTC medications during 
their pregnancy. The data is analyzed by use of descriptive and inferential statistics and 
presented by way of statistical means. 
 
Results: Of the 555 women, 391 (70.5%) women were taking OTC medications during 
pregnancy. The most reported medications used were; OTC vitamins, heartburn and acid 
reflux medications and analgesics with a percent of use 98.0%, 97.7% and 46.8% 
respectively. 67.8% of these mothers were in the ages between 20-40, and 64.1% were 
overweight women. The majority of those taking OTC medications during pregnancy had 
been directed by the doctors (58.2%), while the pharmacists were the lead source of the 
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information (83.1%). 65.0% of pregnant women thought that OTC are safe, but with 
consultation of the professionals and 29.5 % thought that they are totally unsafe.  
 
Conclusion:  
This study is the first study that detected the prevalence of OTC medications use in 
Palestinian pregnant women. The prevalence of use was high. We have identified the 
predictors of OTC medications use and the problems faced during pregnancy leading them 
to take OTC medications. The lack of awareness on using these medications during 
pregnancy is alarming.  Educational programs should be held for increasing the awareness 
among pregnant women on the effects of OTC medications on their pregnancy. 
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Terminology:    
Comorbidity  The presence of co-existing or additional Diseases with reference to an 
initial Diagnosis or with reference to the index condition that is the 
subject of study. Comorbidity may Affect the ability of Affected 
individuals to function and also their Survival; it may be used as a 
prognostic indicator for length of Hospital Stay, cost factors, and 
outcome or Survival. 
 
Miscarriage  Expulsion of the product of Fertilization before completing the term 
of Gestation and without deliberate interference. 
Morality All deaths reported in a given Population. 
Nullaprity  The state of never having delivered a live child. 
OTC Medicines that can be sold legally without a Drug Prescription. 
Parity The number of offspring a female has borne. It is contrasted 
with Gravidity, which refers to the number of Pregnancies, regardless 
of outcome. 
Premature Onset of Obstetric Labor before term (Term Birth) but usually after 
the Fetus has become viable. In Humans, it occurs sometime during 
the 29th through 38th week of Pregnancy. Tocolysis inhibits 
premature labor and can prevent the Birth of Premature Infants (Infant, 
Premature). 
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1. Chapter One 
_________________________________________________________  
 
1.1 Background of the Study 
 
The use of over the counter medication is increasingly becoming an issue of the day with 
regards to pregnant women; this is attributed by the fact that most women do not know 
they are pregnant until after a few months (Sachdeva et al, 2009 ). Awareness of the effects 
of OTC medication on pregnant women appears to be quite low. In most cases, pregnant 
women think that OTC medicine may just address the health issue it is prescribed for and 
do nothing further. Healthy birth is one of the key drivers of parents wanting to get 
children; therefore, medication concerns should not only be for the mother, but should also 
be extended to the fetus because it stands to suffer more effects than its mother. It is 
usually hard for a pregnant woman to know which medicines are harmful to her health and 
pregnancy and those that are not; whether they are prescriptions by doctors or OTC. All 
over the world education programs have been started for pregnant women. These are aimed 
at reducing the number of births with defects. 
 
Previous research in the USA has shown that 30% of the OTC medications that were 
available in the markets between the years 1975 and 1994 had been used as prescription 
medicines. According to the research 80% of the pregnant women in America are users of 
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OTC medications. Of the 80%, only 60% of them seek the doctor’s advice when they are 
selecting OTC medications. This research showed that at least 10% of all the birth defects 
are caused by drug exposure to the fetus. Since 1975, the FDA has commissioned studies 
on the risk factors of all drugs used in the USA by pregnant women. They have failed to 
research enough for most of the drugs during the pregnancy period due to ethical factors. 
Health professionals are expected to be knowledgeable about medicine, yet are unlikely to 
have received any specific education about prescribing to pregnant and breastfeeding 
women, a recent study survey showed that practitioners (GPs) advised women to avoid 
breastfeeding while taking medicines like metronidazole and ibuprofen. Furthermore, 
research has shown that health professionals often rely on the safety ratings given to 
medicines in pregnancy when making decisions about prescribing for breastfeeding women 
(Amir, 2011).  
 
 Adaptation to pregnancy is a vital component of any response to the increasing birth 
defects that are caused by these prescriptions. The degree to which the pregnancy is 
affected by the OTC medication is determined by the mother`s adaptive capacity to the 
pregnancy. For example, aspirin taken up to 8 days in one of the first lunar months of 
pregnancy showed no increase in the rate of malformations, but using Aspirin, even for 
short periods, after the 32
nd
 week of pregnancy should be avoided due to a high incidence 
of premature closure of the ductus arteriosus. Using Aspirin during the third trimester may 
cause a reduction in fetal urine output and consequent oligohydramnios resulting in fetal 
malformations (Young, 1997). 
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Ibuprofen is the safest NSAIDS to be used during pregnancy but there is potential to cause 
premature closure of the ductus arteriosus and oligohydramnios if it is used in the third 
trimester of pregnancy (Young, 1997). 
 
Acetaminophen (paracetamol) is the most commonly used OTC pain and fever medication, 
with more than 50% of pregnant women reporting use in the United States and Denmark. 
Recent human studies suggested that acetaminophen has endocrine disrupting properties 
which may affect neurodevelopment and cause behavioral dysfunction; by interfering with 
sex hormone or thyroid hormone function essential for normal brain development. There 
appears to be an association between acetaminophen consumption during pregnancy and 
children with symptoms of attention deficit/hyperactivity disorder (ADHD), characterized 
by inattention, hyperactivity, increased impulsivity, and motivational/emotional 
dysregulation. Hyperkinetic disorder (HKD) is a particularly severe form of ADHD 
(Olsen, 2014). 
 
Decongestants, antihistamines, and expectorants are also some of the OTC medications 
that have not been studied adequately. Due to the lack of adequate information on these 
drugs, some physicians avoid prescribing these medications to pregnant women (Werler, 
2005).  
 
Use of Decongestant agents may increase the blood pressure or even result to constrictions 
in the uterine arteries; thus could affect the flow of blood to the fetus. This theory is 
debatable. 
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In the year 2000, the Obstetricians and Gynecologists Association of America together 
with the Allergy Association of America recommended the use of pseudoephedrine is the 
best choice of decongestant to pregnant women (Black and Hill, 2003).. This 
recommendation was based on studies that were done on animals. However, due to the fact 
that this medication may be associated with gastros chisis (a congenital defect 
characterized by a defect in the anterior abdominal wall through which the abdominal 
contents freely protrude), pregnant women should not consider it as their first option and it 
should be recommended when the benefits are outweighing the risks involved. 
Antifungal agents such as imidazole, clotrimazole, and butoconazole are some of the drugs 
that are available over the counter. Results of Firth et al. (2014) review investigated a 
specific antifungal showed that  there is no relationship between the antifungal and any 
fetal disorders. 
 
Some reports stated that malformation of the fetus may be caused by the use of antacids 
that contain high levels of aluminum; however, there was not enough data to back up these 
reports. Most doctors will prefer to administer antacids that contain calcium rather than 
those that contain magnesium sulfate (Elise J Smolders, 2013). 
 
PPI (proton pump inhibitors) is mostly used to treat acid related complaints (Kinoshita 
and Ishihara , 2008). Controlled examinations on the long term and short term safety of the 
PPI treatment showed that 30 to 50% of pregnant women suffer severe heart burns 
(Richter, 2005). Sometimes this heart burns exacerbate gastroesophageal reflux disease if it 
is pre-existent. Baron et al. (1993) showed that 52% of pregnant women first experience 
the heart burns in the first trimester of their pregnancy, 24% in the second, and 9% in the 
third. According to this  review , heartburn is normal in healthy pregnancies. It also 
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reviewed the management and safety of administering the PPI treatment; it revealed that 
PPIs have very minimal effects on the pregnancy. However, to decrease the risks involved 
it is advisable to delay the PPI until after the first trimester since the more the patient nears 
conception the more the risks are increased.  
 
A recent study also showed that some pregnant patients do not utilize the pharmacists 
around them for information regarding their condition and the use of OTC medication. 
26.2% of them go to their friends who have been in the same condition to get advice on 
how to tackle the problem and use similar methods while 44.3% will refer to the internet. 
32.8% of the pregnant women spend their time reading pregnancy books and journals to 
get answers on their condition. These sources have become more popular than the 
pharmacists, whereas the pharmacists are the ones supposed to have the most reliable 
information (Coomans, 2013).  
 
Long term interventions may lead to a reduction in the number of malformed fetuses and 
babies; however, the greatest challenge facing this kind of intervention is the inability to 
reach all the pregnant women, which so far has proven to be impossible. This is 
complicated by the fact that some developing countries still have pregnant women giving 
birth at home, and some still use traditional methods of birth and hence cannot access the 
advice that is offered by the doctors in hospital on the use of OTC medications. The 
Ministry of Health has been advocating for pregnant women to visit the health centers and 
receive the doctor’s advice on matters that concern their pregnancy. Over the years, 
colleges and NGOs have been working hard to study the various medicines that are offered 
over the counter to determine those that are advisable for pregnant women to use and 
which ones are hazardous to the health of their fetus. 
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1.2 Statement of the Problem 
  
Medical therapy with pharmaceutical agents is of great concern to the wellbeing of the 
international society. Today most of the effects of OTC medications are not known to 
patients and even to the pharmaceutical professionals themselves. Some of these effects 
caused by these medicines are hard to treat and are irreversible. Given that this medication 
adversely affects the quality of human life; they should not be restricted based solely on 
the pregnancy. Most times the pharmacists do not have answers to their patients 
concerning which OTC medication to take and their effects on the baby. This will push the 
pregnant patients to seek help elsewhere, for example, in books and on the internet. 
 
1.3 Research Questions 
 
What is the prevalence of over-the-counter medication use among pregnant women in the 
Palestinian West Bank?  
What type of OTC medications used during pregnancy?  
What source of information is used to select OTC medication during pregnancy? 
 
1.4 Research Objectives 
 
To measure the prevalence of over-the-counter medication use among pregnant women in 
the Palestinian West Bank  
To determine the type of OTC medications used during pregnancy. 
What source of information is used to select OTC medication during pregnancy. 
Factors and practices that have so far hindered awareness on the effects of OTC medication 
on pregnant women. 
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1.5 Justification of the Study 
 
There is a need to take care of the pregnant women in the community. Most of these 
women suffer from various diseases during pregnancy and most of them do not understand 
why until it is a little too late when they have already given birth to a deformed child. 
Giving birth to a child who is deformed is a painful experience for any mother. 
 
Development of awareness campaigns has been in practice for a long time. However, the 
results are not all that visible if you look at the number of women that are giving birth to 
children with defects due to the OTC medications. The work of these institutions needs to 
be synchronized with the activities of extension departments. There is a need for the 
development of policies that ensure the strides of development made on the research front, 
in terms of development of effective awareness campaigns, is matched with the actual 
effects of OTC medications on the ground. This study thus seeks to find out the most 
effective way to curb the problem of birth defects that are caused by OTC medications and 
the factors that hinder the development of adequate awareness to the pregnant mothers on 
the threats that are posed by taking over the counter medications. Before one starts with 
awareness, we need to understand the situation in the Palestinian community from 
prevalence of use, to types of medications used, to sources of advice or information for the 
use of OTC medications during pregnancy. 
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2. Chapter Two:  
____________________________________________________________ 
 
Literature Review 
 
2.1 Introduction 
 
OTC medicines are those medicines that are offered over the counter of shops without the 
prescription of doctors. The presence of a clear plan of action by way of policy 
formulation, involvement  of instructional stakeholders and putting all efforts towards 
sensitization and awareness creation on the potential of giving birth to children who are 
100% healthy by the pregnant mothers needs to be exploited. 
 
 This section thus carries a review of previous work by other scholars on the effects of 
OTC medications with the major focus on pregnant women. 
 
2.2 Level of Awareness of the Effects of OTC Medications by Pregnant Women 
 
The level of awareness on the effects of OTC for pregnant women has been on the rise 
owing to efforts by institutions and organizations such as WHO and the Boston university 
epidemiology center (BDS). Since 1976, such institutions have earned accolades for 
enormous strides made towards creating awareness on the effects of OTC medications 
(Mehnert, 2012). The  lack of a linkage between the institutions and the service providers 
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and the absence of synergy between industries, research institutions, and the service 
providers have caused the failure of progress on the research fronts trickling down to the 
doctors and pharmacists. This is attributed to the lack of up to date avenues to share 
information to stimulate technology transfer (Kline, 2011). 
 
Tilley (2006) carried an investigation about similar situations in Europe. It was interesting 
to find that expectant mothers across the board tend to make similar decisions at the time 
of expectancy. In his study, he noted that in UK, Belgium and Italy where birth rate is 
almost half that in the Middle East, the authorities heavily provide both financial and 
information resource.  
 
Institutional bottlenecks in terms of research capacities and facilities for awareness 
creation have been the undoing of the awareness creation mediums. Institutions invest a lot 
of resources into the development of equipment, which most of the times are of little use to 
the pregnant women in the society. Emphasis should be placed on building awareness and 
enlightening the pregnant women on the risks they face when they take OTC medicines 
without the approval of a pharmacist or a doctor; enlightening the pregnant women helps 
them to derive maximum benefits from the awareness programs (Amir, 2011). 
 
Studies have indicated that women with a higher level of awareness of the effects of OTCs, 
lower their risk of miscarriage and having children with hyperkinetic disorders.  According 
to Jama Pedriats 70% of expectant women admit to have been taking the OTCs without 
knowledge of their side effects. This research further shows that 42.6% of those women 
experience some kind of complication either during pregnancy or while giving birth. 
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2.3 Factors and practices that hinder OTC medication effects awareness to pregnant 
women:  
 
There are various factors that bar the awareness campaign from being as effective.  
For example, lack of availability of a health center near the patients` location.  
Pregnant women find it hard to travel now and then to go to a clinic. This makes some 
consider their problem as minor if it is a headache, heartburn and other small problems. 
Most of them may end up going to the nearest drug store and buy some medicines without 
knowing the effects the drugs will have on the fetus. Apparently, 46% of these women 
admit that they frequently visit a pharmaceutical outlet or chemist to buy medications for 
pain, cough, nausea and backache. The level of education is also an important factor for 
women who are pregnant for the first time; most of them do not know what they are 
supposed to do when faced with certain challenges during their pregnancy (Amir, 2011). 
 
The British Medical Journal (2004) identifies poverty, policy failure and other mainstream 
factors as leading factors that raise the risk of complication during pregnancy.   
 
The study carried out by the physicians’ involved named regions in Africa, south Asia and 
Middle East as high risk areas for child birth during pregnancy.  
 
Constraints at the policy framework level have caused the lack of awareness on the OTC 
medication effects on pregnant women. Some of these constraints are caused by the fact 
that some institutions have the sole development rights, lack of affordable credit and also 
some of the institutions compete with each other instead of working together (Ekor , 2013). 
Poverty may also be another hindrance. Some of the pregnant women who are poor 
sometimes cannot afford to visit the doctor or physician, every time they are faced with a 
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minor health problem, to consult them on the safety of the medication that they intend to 
use(Swartz, 2009). Research by various institutions has also proven to be of less value 
today mainly because of the fact that most of these research facilities offer different results; 
results from one institution cannot be backed by results from another institution. This 
creates confusion to the pharmacists on what medication they should offer to their pregnant 
patients. They may end up giving prescriptions of a drug that has worse defects on the 
fetus than another, for example, a research by the American college of Obstetricians and 
Gynecologists in the year 2000, recommended the use of pseudoephedrine as the 
decongestants of choice (Black and Hill, 2003).. However, later studies showed that patients 
should avoid this medication as it may result in gascroschisis (Kline and Westberg, 2011). 
It should be used when there is no other option available. This shows that some studies are 
inconclusive and cannot be depended upon while others are derived from mere 
assumptions. 
 
2.4 Various Awareness Campaigns 
 
A lot of institutions and organizations in the field of medicine try to create awareness on 
the effects of OTC medication on the pregnant women. Studies by the Slone Epidemiology 
Center on birth defects tested its hypothesis on 12,734 who had defect cases and 7,606 
infants who were not malformed in the USA and Canada. The hypothesis showed a few 
associations with oral and intra nasal decongestants (Coomans, 2013). Publishing such 
findings in magazines and other media increases the level of awareness amongst patients. 
These findings should also be taught to pharmacists in institutions or seminars and this way 
they can transfer their knowledge to their patient. This will be a great step in solving the 
issue of awareness and education on OTC medication. The pregnant mothers should be 
well aware of the defects the child is likely to suffer due to some of these medications. 
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2.5 Institutional Support as a Factor that Affects OTC Medication Awareness 
  
The functions of a research institution are to develop suitable results on the effects of OTC 
medications. Researchers should synchronize their research and development with 
extension services whereby patients are linked with their service providers who have the 
current best practice in mind. This has proven to be a great challenge in many countries. 
Sometimes this is challenged by the accessibility of the service provider by the patient; 
therefore, a lot of resources have to be extended to those pregnant women that live in such 
areas. Sometimes the research facilities do not extend their abilities to their full potential. 
This causes a slowdown in the ability of the institution to deliver results to the intended 
patients (Werler, 2005). 
 
Brazier and Prayle (1998) also looked at the reality of OTC and other medicines ingested 
during pregnancy. Apparently, many mothers that take these medicines do not report 
because they do not see the need to or simply forget. Others use the OTCs to temporarily 
ease their discomfort. The use of home based care and self-healing techniques sometimes 
complicates the issues. Institutions have a responsibility to put in place initiatives that give 
the mothers proper information. 
 
2.6 Summary and Gaps to be filled 
 
Glover et al. (2003) conducted a study to identify the over the counter and herbal 
medication in rural areas. . In their results, they established 92.6% of the people living in 
the rural areas self-medicate themselves with one OTC product. 45.2% of those people use 
herbal medicines and 20.8% took more than one OTC medication during their pregnancy 
period. The study made note of an increase in the use of the medicines as the pregnancy 
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progressed. The most common OTC medications that had been used included; aspirin, 
prenatal vitamins, ibuprofen, and non-sedating antihistamines. 
 
A larger retrospective study. conducted by the Slone Epidemiology Center in collaboration 
with the  National Birth Defects Prevention Study, involved 10,000 pregnant women. 
According to this study, the most commonly used OTC medicines were acetaminophen, 
guaifenesin, diphenhydramine, and pseudoephedrine. The study discovered an increasing 
trend in the use of these medications. Analgesics and decongestants were most popular 
with white women who had attained the age of 20 years and above and those who had at 
least attained a high school education (Kline and Westberg, 2011). 
 
Kline and Westberg, 2011 showed most of the pregnant women who use prescribed 
medicine are also likely to use OTC medications. White women, who were well educated, 
married, and those who were older and used alcohol, marijuana, and caffeine used OTC 
medicines more than any other group. Most of these studies try to prove or show the 
association of OTC medication and the maternal effects they pose to the pregnant women. 
There are no relevant articles that direct the pregnant mothers on where they can access 
this information or even give recommendations. There are no existing articles that give the 
view of pregnant women on the safety of the OTC medications (Peters et al., 2013). 
Pharmacists can provide important information and instructions to their pregnant 
customers; there are very few or no studies on pharmacists. Relevant education to the 
pharmacists can enable them to teach pregnant women that most of the drugs that are 
offered over the counter lack any evidence as to their safety. The goal of this study was to 
gather and analyze data related to OTC medicines, study the decision making behaviors of 
the pregnant women and their beliefs (Kline and Westberg, 2011). This will assist the 
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pharmacists to offer quality advice to their patients on which medications to use and which 
ones to avoid. 
Dudin (2001), between 1986 and 1995,  had reported a total of 730 stillbirths at Al-
Makased Hospital, out of them , 156 (21%) had congenital anomalies, also he reported 828 
neonatal deaths, out of them as did 306 (37%) had congenital anomalies .  
 
There are limited studies about using OTC medications during pregnancy among 
Palestinian pregnant women. However,  Al-Ramahi et al. ( 2013) had conducted a study to 
find the prevalence of using herbal medications . they found about 40.0% of the pregnant 
women were used herbs during their pregnancy, most of them (82.5%), because they 
thought that herbs are safer than OTC or prescribed medications.  
 
Another study conducted by Shtayeh et al. ( 2015) , to evaluate the plants used during 
pregnancy and infant childbirth, postpartum and infant healthcare in Palestine. The study 
found that  72.3% of the women been interviewed reported that they used herbs at different 
pregnancy stages and for infant healthcare.  
 
Sawalha 2007 conducted a cross sectional study in Palestine in which consumption of 
prescription and non-prescription medications by pregnant women was evaluated. Maternal 
intake of medications and supplements has changed over time, and it may be related to 
adverse reproductive outcomes. Pregnant women attending the prenatal clinic at Rafedia 
Governmental Hospital at Nablus/Palestine were interviewed using a questionnaire 
containing questions regarding medications intake and disease status. Of the pregnant 
women attending Rafedia prenatal clinic, 70.2% were village residents, 89.9% of them had 
no chronic diseases at the time of pregnancy except for anemia which was a common 
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condition. More than half of the pregnant women did take vitamins, iron, and calcium 
(56.4%, 63.3%, 57.8%, respectively) during pregnancy. Less than fifty percent of the 
pregnant women took folic acid. Nausea and vomiting were common but most women did 
not take any medications to treat it. Less than one third of the pregnant women took over 
the counter (OTC) medications, mainly analgesics, and more than two thirds took 
prescription only medications (POM), mainly antibiotics. Mean medication intake per 
pregnant woman was 1.6±0.9. Most of the women who took medications did take only one 
(44.5%), a lesser percentage took two (30.8%) or more (9.3%) medications. The 
medications taken belonged to categories B and C, and few belonged to category D. About 
45% of pregnant women used herbal medications to treat mainly GIT problems such as 
upset stomach, diarrhea, and constipation. The majority of pregnant women in this study 
did not visit a dentist during their pregnancy. The study concludes that women and health 
care providers need to be educated about the importance of supplement intake during 
pregnancy. Self-medicating or doctors prescriptions of POM, OTC, and herbal medications 
during pregnancy support the importance of expanding the knowledge about the potential 
risks and benefits of such treatments.  
This was supported by another cross sectional study that was conducted by Abu Arah 
(2012) in Palestine to assess knowledge of community pharmacists about safety of 
medicines during pregnancy and evidence based therapy of herbal products. The sample 
consisted of 342 pharmacists. Data was collected by self-administered questionnaires. The 
findings showed insufficient competence in providing information about safety of 
medications during pregnancy among community pharmacists. The study justified such 
results to lack of knowledge in certain aspects of pharmacy practice such as, evidence 
based indication of herbal products, herbal-drug interactions and medication safety during 
pregnancy. This study concluded that the government, universities and pharmaceutical 
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association should provide community pharmacists with continuous and up-to-date 
medication knowledge to improve patient counseling. The study recommended 
establishment of pharmacy continuing education center and make such education 
mandatory for re-licensure in Palestine (Abu Arah, 2012). 
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3. Chapter Three:  
____________________________________________________________ 
Research Methodology 
3.1 Introduction 
 
This chapter looks at the research design and the methodology employed to carry out the 
study. It clarifies the research design and explains the sampling procedure and the criteria 
used for selection. This section also describes the research instruments used and the 
procedures followed in their administration towards the target group. The chapter also 
brings out the procedures used to analyze the data. 
 
3.2 Research Design 
 
The descriptive research design is used in the study. This is appropriate approach that can 
be used to get the results of the study without any manipulations of the findings. The 
descriptive design can be used when the research problem is specific, and in our case study 
has an emphasis on the prevalence use of OTC medications by pregnant women.  
 
3.3 Target Population 
 
The target population is mothers who visited the selected healthcare centers and clinics in 
the area of the study. 
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This survey was carried out at a group of governmental healthcare centers and Gynecology 
private clinics and hospitals in Nablus (North), Ramallah (Center) and Hebron (South) 
cities between 22, January 2014 to 22, January 2015. 
 
3.4 Sampling Procedures 
  
The Study was carried out in the  main Governorate Hospitals; Rafidia Hospital and Al-
Watani Hospital in Nablus (north), Palestine Regional Medical Center & Rehabilitation 
Hospital in Ramallah (center), Alia Hospital and Al-Ahli Hospital in Hebron (South) . The 
interviews took place at private clinics and at the governmental mother care centers   in the 
three mentioned areas. The sampling process was stratified by site to get the number of 377 
samples. 
 
3.5 Sample Size 
  
The minimum sample size of this study was calculated to be 377 mothers based on Roasoft 
sample size calculator. The study investigator tried to get more than the minimum samples 
required and the actual sample size ended up being 555 pregnant women. 
             
3.6 Research Instruments 
 
 The study employs the use of questionnaire to interview the targeted women by a trained 
research staff that helped in collecting the data, as a data collection tool. The questionnaire 
had both open and closed ended questions The questionnaire was written in English 
(Appendix1), and the questions were designed according to similar studies were taking 
place in different countries. The questionnaire translated into Arabic (Appendix 2); then 
translated back into English; and finally, compared of the back translation with the original 
English version by two  of bilingual researchers. A pilot study of a sample of 20 subjects 
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(not included in the final analysis) was conducted to ensure that the final draft was clear, 
understandable and acceptable. The reliability of the questionnaire was assessed using 
Cronbach’s coefficient alpha, the internal consistency of the instrument was 0.71. 
The data was collected by interviewing the expected mothers personally, interviewing the 
expected mothers and not only distributing the forms to be filled helped in minimizing 
wrong or any biased collected data. 
 
3.7 Data Collection Procedures 
 
The study was approved by a committee of the Palestinian Ministry of Health (Appendix 
3). The data were collected by interviewing the pregnant women, to observe and infuse the 
inputs of the targeted women with regards to the situation on the ground. 
 Information on demographic characteristics—including age, gender, education, and 
occupation and smoking status was collected. The interview also included questions related 
to the clinical situation and treatment of ailments. Information on Prescribed medication, 
OTC medication, GP and midwife visits, BMI, Null-parity and gravidity were also 
obtained. 
 
3.8 Data Analysis 
 
Data from the questionnaires were collated, statistically analyzed by use of descriptive 
statistics and inferential statistics. The data collected was analyzed using SPSS version 
21.0; a data analysis software. Results are presented and discussed in tables, pie charts, and 
computed in percentages.  
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4. Chapter Four:  
_______________________________________________ 
Results   
555 women participated in this study; they asked to answer a questionnaire during their 
pregnancy, by interviewing each one personally. Out of the 555 women, 391 women 
70.5% (Table 4.1 and Figure 4.1) used OTC medications during pregnancy, with an 
average of 2.54 medications per pregnant woman. The most reported medications used 
were; OTC vitamins 98.0% (AP5.Table 22), heartburn and acid reflux medications 
(97.7%) (AP5. Table 19), cold, cough or sore throat drugs (AP5. Table 18) were 2.3%, 
constipation, diarrhea, or upset stomach drugs were used by 9% (AP5. Table 20), allergies 
medications were used by 1% (AP5. Table 21) and analgesics were used by 46.8% 
(Tab.18). 
The characteristics of the pregnant women and the results in relationship with OTC 
medications use during pregnancy are summarized in Tables 4.2, 4.3, 4.4 , 4.5 and 4.6. 
Pregnant women were more likely to take OTC medications during pregnancy if their age 
is between 20-40 (Table 4.2), over weight (BMI = 25-29.9) (Table 4.3) . 30.8% women 
who used OTC had no high school degree (Table 4.2) and in their second trimester (Table 
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4.4), did not have previous obstetric complications (miscarriage, prematurity or child 
mortality), nor Null-parity (Table 4.5) . 
Table 4.5 shows 52.9% reported gravidity of 3 times or more, 25.9% showed parity of 4 or 
more. 64.5% were on-smokers and 98.9% did not consume alcohol (Table 4.3), 59.1% of 
the women who consumed OTC reported general practitioner visits of 3 times, 64.9% of 
them showed did not visit midwife during pregnancy (Table 4.4). 87.2% of the women 
who consumed the OTC showed no comorbidity conditions and out of the women who 
used OTC during pregnancy, 45.2% used additional prescribed medication (Table 4.6). 
 
Table 4.1: Taken any over-the-counter (OTC) medications during your 
current pregnancy among respondents. 
 Frequency % Valid Percent Cumulative Percent 
Yes 391 70.5 70.5 70.5 
No 164 29.5 29.5 100.0 
Total 555 100.0 100.0  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: The percentage of taken OTC medications during current pregnancy 
among respondents.  
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Table 4.2: Socio-demographic predictors and results of the relationship to OTC 
medications use. 
Predictor N % 
OTC 
medication use 
% 
No OTC 
medication use 
% Df P (Chi 2) 
Age 
Less than 20 162 29.2 94 24.0 68 41.5 2 0.00 
20-40 352 63.4 265 67.8 87 53.0   
40-60 41 7.4 32 8.2 9 5.5   
Highest level of Education 
Less than high 
school 
171 30.8 102 26.1 69 42.1 4 0.00 
High school 
diploma 
106 19.1 69 17.6 37 22.6   
College or 
technical 
degree 
136 24.5 125 32.0 11 6.7   
4-year college 
degree 
109 19.6 95 24.3 14 8.5   
Professional or 
graduate 
degree 
33 5.9 0 0.0 33 20.1   
 
Table 4.3: Lifestyle predictors and results of the relationship to OTC medications use.  
Predictor N % 
OTC 
medication 
use 
% 
No OTC 
medication 
use 
% Df P (Chi 2) 
BMI  
<18.5 2 0.4 0 0.0 2 1.2 3 0.00 
18.5-24.9 193 34.8 81 20.7 112 68.3   
25-29.9 356 64.1 310 79.3 46 28.0   
>30 4 0.7 0 0.0 4 2.4   
Smoking during pregnancy 
Yes 197 35.5 178 45.5 19 11.6 1 0.00 
No 358 64.5 213 54.5 145 88.4   
Alcohol consumption during pregnancy 
Yes 6 1. 1 4 1.0 2 1.2 1 0.84 
No 549 98.9 387 99.0 162 98.8   
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Table 4.4: Current obstetric situation predictors and results of the relationship to OTC 
medications use. 
Predictor N % 
OTC 
medication 
use 
% 
No OTC 
medication use 
% Df P (Chi 2) 
Current Pregnancy Trimester 
0-3 months 54 9.7 38 9.7 16 9.8 2 0.00 
4-6 months 196 35.3 195 49.9 1 0.6   
7-9 months 305 55.0 158 40.4 147 89.6   
General Practitioner visits 
0 29 5.2 0 0.0 29 17.7 3 0.00 
1 53 9.5 46 11.8 7 4.3   
2 145 26.1 45 11.5 100 61.0   
3 or more 328 59.1 300 76.7 28 17.1  
 
 
Extra midwife visits 
0 360 64.9 345 88.2 15 9.1 3 0.00 
1 51 9.0 10 2.6 41 25.0   
2 22 4.0 0 0.0 22 13.4   
3 or more 122 22.0 36 9.2 86 52.4   
 
Table 4.5: Obstetric history predictors and results of the relationship to OTC medications 
use. 
Predictor N % 
OTC 
medication 
use 
% 
No OTC 
medication 
use 
% Df P (Chi 2) 
Miscarriage 
Yes 194 35.0 157 40.2 37 22.6 1 0.00 
No 361 65.0 234 59.8 127 77.4   
Prematurity/ mortality 
Yes 132 23.8 123 31.5 9 5.5 1 0.00 
No 423 76.2 268 68.5 155 94.5   
Nullparity 
Yes 58 10.4 58 14.8 0 0.0 1 0.00 
No 497 89.6 333 85.2 164 100.0   
Gravidity 
1 155 27.9 61 15.6 94 57.3 2 0.00 
2 106 19.0 106 27.1 0 0.0   
3 or more 294 52.9 224 57.3 70 42.7   
Parity 
0 81 14.6 79 20.2 2 1.2 4 0.00 
1 91 16.4 78 19.9 13 7.9   
2 139 25.0 96 24.6 43 26.2   
3 100 18.0 42 10.7 58 35.4   
4 or more 144 25.9 96 24.6 48 29.3   
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Table 4.6: Comorbidity predictors and results of the relationship to OTC medications use. 
Predictor N % 
OTC 
medicati
on use 
% 
No OTC 
medicatio
n use 
% Df P (Chi 2) 
Comorbidity  
Yes 71 12.8 25 6.4 46 28.0 1 0.00 
No 484 87.2 366 93.6 118 72.0   
Have any healthcare professional prescribed you any drug (Prescription drugs) 
Yes 251 45.2 197 50.4 54 32.9 1 0.00 
No 304 54.8 194 49.6 110 67.1   
 
When pregnant women that used OTC medications during pregnancy were asked about the 
recommender of using OTC medications, the majority of pregnant women have been 
directed mainly by doctors (82.6 %), and the rest have been recommended by midwives or 
nurses (12.3 %), using by themselves ( 4.1%) , and   only  1% were recommended to use 
OTC  by the pharmacists ( Table 4.7)   
 
Table 4.7 Distribution of OTC medications recommenders. 
OTC recommenders Frequency % Valid Percent Cumulative Percent 
Physician/Doctor 323 82.6 82.6 82.6 
Midwife/Nurse 48 12.3 12.3 94.9 
Pharmacist 4 1.0 1.0 95.9 
I chose on my own 16 4.1 4.1 100.0 
Total 391 100.0 100.0  
 
Otherwise, when those pregnant women were asked about the source of information of 
using OTC medications during pregnancy, pharmacists were the majority source of 
information for those women (82.9%), while only 9.2% got the information from 
physicians. Internet and social relationships were also sources of information for pregnant 
women about OTC medications, as 6.9% were searching on the internet or asking friends 
or family.  Only 1% asked midwives or nurses (Table 4.8). 
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Table 4.8: Source of information  about the OTCs for pregnant women 
 Frequency Percent % Valid % Cumulative % 
Physician/Doctor 36 9.2 9.2 9.2 
Midwife/Nurse 4 1.0 1.0 10.2 
Pharmacist 324 82.9 82.9 93.1 
Internet, Family and friends 27 6.9 6.9 100.0 
Total 391 100.0 100.0  
 
Safety is the major concern for pregnant women, for themselves and their infants. The 
thought of the safety of OTC herbal or drugs use during pregnancy will affect the 
prevalence of use of these medications , 361 (65.0%) of pregnant women thought that OTC 
are safe, but with consultation of the professionals (Doctors or pharmacists) before using 
them, 27 (4.9%) thought of the safety of these medications, but they would check the 
safety on the internet or asking friends or family. 3 women (0.5%) thought that they are 
totally safe to be used during pregnancy, and 164 (29.5%) thought that they are extremely 
unsafe (Table 4. 9). 
Table 4.9: The thought of the safety of [OTC, Herbal, Vitamin] use during pregnancy   
How safe do you think [OTC, Herbal, Vitamin] 
are during pregnancy? Frequency % 
Valid 
Percent 
Cumulative 
Percent 
Very safe, I don't need to talk to a healthcare 
professional before using. 
3 0.5 0.5 0.5 
Safe, but I would talk to a healthcare professional 
before using. 
361 65.0 65.0 65.6 
Safe, but I would check with resources, such as 
friends or the Internet, before using 
27 4.9 4.9 70.5 
Unsafe, I would not use these during pregnancy. 164 29.5 29.5 100.0 
Total 555 100.0 100.0  
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5. Chapter Five:  
_______________________________________________ 
Discussion    
 
In this study, we found that the prevalence of using OTC drugs during pregnancy among 
Palestinian women was 70.5%. This study is the first one has been conducted in Palestine 
study the predictors of using OTC during pregnancy; because of this, it was difficult to 
compare our results with previous results. Glover et al. (2003) found that in United States 
the prevalence of using OTC medications among pregnant women was 92.6%, while 10 
years before in 1993, Rubin et al. found that using OTC by pregnant women was 53.6%. 
This highly increased in the prevalence among these years, could be explained by the 
widespread of the internet, and due to the easy access to pharmacists to ask for their 
recommendations. Nowadays most pregnant women go on a regular checkup with their 
doctor to make sure the fetus is growing well with no abnormalities shown, this makes it 
easier for physician to dispense the OTC as needed for pregnant woman. A recent study in 
2011, which had been conducted among Hispanic American pregnant women, found that 
the prevalence of using OTC during pregnancy was just 23% (Bercaw et al., 2010). This 
could refer to the high awareness of women these days, and knowing that any medication 
may  affect their health and might affect the fetus somehow during pregnancy or after 
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birth, nowadays some disorders might be related to medication use during pregnancy, and 
this makes  the decision of taking OTC by themselves more prudent.     
From the results, the age of the mothers and the level of education influenced using OTC 
medications during pregnancy. AP4. Table 1 shows the relationship between age of the 
respondents and taking OTC (P<0.05), 67.8% of those expectant mothers in the ages 
between 20 and 40 were reported to take an over the counter drug. This is unlike the 24% 
of those below 20 years and 8.2 % of those in the 41-60 brackets. Women in the ages 
between 20 and 40 are more likely to have previous pregnancies, more relationships, and 
they are more confident to take decisions than younger of 20 years. Also, older women in 
their expectancy stages seem to take OTCs less than those in the younger years, as their 
experiences much wider than the younger and maybe they can handle the unserious health 
condition without using any medication, and may not be willing to take any small chance 
to affect the fetus and maybe when an older woman gets pregnant, she is already worried 
about some genetic complications that might affect the fetus because of her late age, so 
they try to avoid anything that might affects the pregnancy in anyway . 
The level of education and the intake of OTC have unique results as shown in AP4. Table3 
(P<0.05). The respondents who are classified into five sections of highest education 
achieved give different outcomes. These classes include those less than high school, high 
school level, college degree, 4 years degree, and post graduate degree. Out of 171 
respondents below high school which represent 30.8% from total sample, 26.1% indicated 
to have taken an OTC while 42.1% did not. The high school diploma holders who 
represented 19.1% of the total respondents recorded a 17.6% versus 22.6% intake to no-
intake ratio. College or technical degree holders who were 24.5% of the total respondents 
represented a 32.0% to a 6.7% OTC intake to no-intake ratio. The professional graduates’ 
expectant mothers who were 5.9% of the total respondents recorded a 0% to 5.9% intake to 
 28 
no intake ratio. P <0.05 this indicates that there is relation between the education level and 
using the OTC during the pregnancy. It shows that professionals with graduate degree level 
avoid taking medication or maybe as we mentioned earlier the more educated they get the 
wiser they are. And a women with a professional level most likely to be older in age with a 
wide knowledge because of her scientific level. 
For the aspect of trimester expectancy, it shows P<0.05 to have a big relation between 
using the OTC and the trimester. Out of 555 respondents, 9.7%, 35.7% and 55% represents 
the first, second and third trimester respectively. The first trimester had a percentage intake 
of OTC to be 9.7% while the second and last had 49.9% and 40.4% respectively while the 
rest do not acknowledge to taking the OTC. The first trimester of pregnancy is sensitive; 
women in this period are extremely cautious about taking any drug that might affect the 
baby or cause miscarriage. The results indicate that more women take OTC during the 
second phase of their expectant period. 
In this study, we found almost 3 out of 10 respondents have reported a miscarriage. The 
statistics indicates that out of 194 of those that did miscarry, 157 still use OTC while only 
37 did not. Therefore the relationship between miscarriages versus OTC intake appears to 
be proportional, and this could be a factor in their miscarriage (P<0.05).  
Also, there appears to be a relationship between previous premature birth or mortality 
(Infant death after born) and OTC intake (P<0.05). Out of the 555 respondents that were 
taken to task, 132 indicated to pass a previous prematurely or mortality, while 423 did not. 
Out of the 132, 123 women took OTC drugs during pregnancy while 9 had previous 
prematurity/mortality but did not take OTC during pregnancy (AP4. Table 6). This 
statistical finding should be interpreted with caution since out of the 423 ladies who did not 
pass previous prematurity/mortality, 268 were taking OTCs during pregnancy. 
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On the aspect of Nullparity, 58 respondents out of 555 had Nullparity the 58 women were 
OTC users. 89.5% of the total sample didn’t experience Nullparity out of this number; 333 
did use OTC but 164 women did not. (AP4. Table 7).  
Gravidity counts (P<0.05) and the level of intake of the OTC have a relationship. 15.6%, 
27.1% and 57.3% represent the women with a single, two or three counts of pregnancy 
respectively, that indicated to be taking OTC while the rest did not (AP4. Table 8). Those 
women that have had more pregnancies seem to be taking more OTCs than those that have 
less counts of gravidity, this might be explained that women with more experience feels 
more confident to use the OTC under the doctor supervision. It showed a relation between 
the number of kids in the family and taking the OTC, where it showed (P<0.05) (AP4. 
Table 9), where the women with OTC intake showed 20.2%, 19.9%, 24.6%, 10.7% and 
24.6% represents the parity count of 0, 1, 2, 3 and 4 respectively. 
Women that smoke were also interviewed to establish their level of OTC intake (AP4. 
Table 10) to show a relationship (P<0.05) between consuming the OTC by pregnant 
women and smoker, 35% of those admitted to smoke while the rest did not. Among the 
smokers, 45.5% took OTC while 11.6% did not. Those who do not smoke and did not take 
OTC are represented by 88.4% of the sample.   
A very small percentage of pregnant women used to take alcohol. Only 1.1% admitted to 
be taking alcohol while 98.9% do not (AP4. Table 11), the result indicate no relationship 
between taking alcohol and taking OTC during pregnancy (P>0.05). 
Women who used to visit the doctor more show more use of OTC (P<0.05), the pregnant 
women with 0, 1, 2, 3 or more visits had a 0%, 11.8%, 11.5% and 76.7% respectively for 
using the OTC (AP4. Table12). But different result can be observed with midwife visit, 
extra visits to the midwife and OTCs have a relationship according to the results too 
(P<0.05). Those that had 0, 1, 2, 3 or more counts of visits to the midwife have 88.2%, 
 30 
2.6%, 0%, 9.2% use of OTC respectively (AP4. Table 13) i.e. the women who did not visit 
the midwife showed a very high rate of OTC use but the women who did visit the midwife 
showed very minimal use of OTC so the relation is inversely proportional between the 
visits and using the OTC of the mothers that were having a disease or a related condition, 
the uptake of OTC have a relationship too (P<0.05). 6.4 % did take OTC medicine while 
28% did not (AP4. Table 14). 
In that perspective, of those that a physician had prescribed an extra drug, 32.9 % avoided 
to take the OTC while 50.4 % took extra OTC, it shows a relation between using OTC and 
a healthcare professional prescribing a prescription drug (P<0.05). All respondents agreed 
to have been referred to take medicines by a given party (AP4. Table 15). 
 This shows that lack of knowledge can lead to poor decisions made during the pregnancy 
period.  
The safety aspect of OTC is one of the most interesting aspects that they reported. Almost 
70% of those respondents agree that they are safe and can be used; they agreed that it won't 
be vital for a person to consult a physician, checking the internet or asking relative or 
friend before engaging in any of the consumption of the medication (AP4.Table 26).  
The results indicate that majority of those that use the OTC has been directed to use them 
by a doctor, nurse or pharmacist. Out of the 391 respondents, 323 used the doctors 
recommended OTCs representing 82.6% portion of the equation (AP4.Table 24). On the 
other hand, pharmacists were the lead source of information, at 83.1% for the OTCs then 
the physicians (9.2%), and  the internet followed suit where represented 6.9%. (AP4.Table 
25). This is an indication that majority of the expectant mothers trust commercial 
pharmacists for information on OTC than physicians, and this support the role of the 
society pharmacists, or maybe the physician does not really give enough time for the 
patient so as to give the right amount of information needed.   
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5.1 The OTC medications taken during pregnancy: 
 
 
Pregnant women seem to suffer from different complications during their pregnancy; these 
complications differ from one pregnant to another. They could be; pain, stomach spasms, 
heartburn or acidity, constipation, diarrhea, allergy …etc. OTC medications could help 
women to get rid of these symptoms.  
The results indicate that the OTC vitamins is the most common OTCs taken by pregnant 
women (98%) (AP5. Table 22) although not all pregnant women need these vitamins. 
These women thought that vitamins are essential for their bodies and their babies, but they 
did not realize that a lot of vitamins could be harmful for the baby, such as vitamin A. 
Heartburn or acid reflux medications are the second common drugs taken by pregnant 
women (97.7 %) (AP5.Table 19); this shows high prevalence of heartburn during 
pregnancy especially during the last trimester, as the baby presses the stomach of the 
mother causing acid reflux into the esophagus. 46.8% (Ap5. Table17) of pregnant women 
that taken OTC medication have taken analgesics drugs, such as; paracetamol, aspirin or 
ibuprofen. These women could suffer from back pain, legs pain, headache… etc.  
We would find the relationship between obstetric history predictors (miscarriage, 
prematurity or mortality, gravidity and Nullparity) with taking of OTC medication by 
pregnant women as explained below. 
As mentioned previously, out of 391 that taken OTC during pregnancy, 157 (40.2%) had 
miscarriage and 234 (59.8%) did not (AP5. Table 5), (P>0.05) shows that there might be a 
relation between the miscarriage cases and using the general OTC during pregnancy. For 
the analgesics drugs (paracetamol, ibuprofen and aspirin), out of the 391 respondents, 
42.7% took these OTCs and had a miscarriage while 49.6 % still took it and did not have 
any miscarriage (P>0.05). This shows that there is no signification relationship between the 
miscarriage and taking these NSAID’s (AP4. Table 19), However, Nielsen et al. ( 2001) 
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and Li et al (2003) , reported an association with taking NSAID'S during pregnancy and  
increased the risk of miscarriage. 
 
Out of the 391 respondents, 9 took cold, cough, or sore throat drugs (nasal sprays, 
Lozenges, pseudoephedrine), only 3 had a miscarriage and 6 did not (AP4. Table 20). 
There is no enough data to determine the relationship between cold drugs and miscarriage, 
but from our data we could report that there is no relationship P=0.67. In the other 
hand,  Erebara et al ( 2008) reported that using cold medications for short term during 
pregnancy does not affect the pregnancy .  
 Most of the respondents were taking heartburn drugs (antacid, famotidine, ranitidine, 
omeprazole), out of 157 that had previous miscarriage, 154 (98.1 %) of them were taken 
heartburn drugs, while 228 (97.4%) that also took these OTCs but did not have miscarriage 
(AP4. Table 21).  From the results, there is no relationship between heartburn or acid 
reflux and miscarriage (P=0.67).  
Gastrointestinal problems are common among pregnant women, but in our data there were 
only 35 respondents were taking OTCs for constipation, diarrhea, or upset stomach 
(laxidin, lopremide), 6 of them had a previous miscarriage and 29 did not (AP4. Table 22). 
The data indicates that there is a relationship between the Gastrointestinal OTC and 
miscarriage (P=0.004) but our sample was a bit small so maybe we will get a different 
result if we have a bigger sample to interview in a different areas. 
  Out of 4 respondents were taken allergic drugs (diphenhydramine, cetirizine, loratidine), 
only 1 had a miscarriage and 3 did not. The data is not enough to determine the 
relationship between these OTCs and miscarriage but as analytical data that shows P=0.53, 
we could say that there is no relationship between this OTC’s and miscarriage (AP4. Table 
23OTC vitamins (vitamin D, calcium, prenatal vitamin, folic acid) are common among 
pregnant women, out of 383 taken these vitamins 154 had miscarriage and 229 did not 
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(P=0.87), this indicates no relationship between OTC vitamins and miscarriage (AP4. 
Table 24).  
 Child premature birth is to get the infant before 37 weeks of pregnancy and this increase 
the mortality of the baby. Prematurity affects the growth and the development of the 
preterm baby. Out of 391 respondents that taken OTCs, 123 (31.5%) had a previous 
premature or mortality baby, and 268 (68.5 %) did not had a premature baby (AP5. Table 
6). 
AP5. Table 28 describes the relationship between OTC medications taken during 
pregnancy and the previous child prematurity or mortality.  
 10 pregnant women (8.1%) were taking analgesics drugs (paracetamol, ibuprofen or 
aspirin) and had a prematurity or mortality, while 173 (64.6%) were taking these drugs but 
did not have premature baby, with a P<0.05. This indicates that there is relationship 
between taking the analgesics OTCs and having premature baby (AP4. Table 25). 
None of the respondents that were taking medications for cold (Ap4. Table 26) or 
gastrointestinal problems (AP4. Table 28) had a premature baby or mortality child 
(P<0.05). From our data we can indicate that there is no relationship between using the 
cold and GI OTCs and prematurity/mortality  
Out of 123 had prematurity or mortality, 114 (92.7 %) were taken drugs for heartburn 
(antacid, famotidine, ranitidine, omeprazole), and all of the respondents that did not have 
premature baby also were taken heartburn drugs, the data here with P<0.05 indicates that 
there is a significant relationship between using the heartburn or acid reflux drugs and 
prematurity/mortality (AP4. Table 27). None of the 35 women who used constipation, 
diarrhea or upset stomach OTC’s had premature or mortality child (AP4. Table 28), the 
data is not enough but according the analysis the P<0.05 which indicates that there is a 
relationship between using this OTC and having a premature or mortality baby. 
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Only 4 (3.3%) women reported that they had taken medication for allergy, all these had 
prematurity or mortality child, but we could not determine the relationship between these 
drugs and prematurity because of the small sample that represent allergic drugs (4 women) 
but we could say there appears to be relationship the P<0.05. 
Nullparity is the condition of the women tried to be pregnant and she did not have any 
child. Out of the 391 that were taken OTCs, 58 (14.8 %) were Nullparity and 333 (85.2 %) 
were not. (AP5. Table 7) shows the relationship between taking OTCs during pregnancy 
and Nullparity. All OTCs have no significant effect on Nullparity, where it shows P>0.05 
(AP5. Table 27). 
Gravity indicates the number of times that woman had been pregnant, regardless of 
whether these pregnancies were continued or not. Out of the 391 respondents, there were 
61 (15.6 %), 106 (27.1 %) and 224 (57.3 %) represented 1, 2 and 3 or more gravidity 
respectively. 
The women who used NSAID’s, cold, cough or sore throat, constipation, diarrhea or upset 
stomach or any of the over the counter vitamins showed a relationship with gravidity with 
a P<0.05. But for the ones who used the heartburn or acid reflux OTC’s or allergies 
OTC’s, it shows no relationship with a P>0.05 (AP5. Table 29). 
Safety of drugs intake during pregnancy is a concern for the pregnant. The majority believe 
that taking OTC is safe but after consulting the physician. AP5. Table 30 shows the 
relationship between thought of safety of OTC and taking them during pregnancy. Almost 
all respondents that have taken OTC medications for cold (nasal sprays, Lozenges, 
pseudoephedrine), gastrointestinal problems (Constipation, diarrhea, or upset stomach) or 
allergy (diphenhydramine, cetirizine, loratidine), thought of the safety of OTCs during 
pregnancy with consultation of healthcare professional with P<0.05. Out of 183 that taken 
analgesics, 112 think of the safety of OTCs after consult physician and 11 think of the 
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safety with checking in the internet, while 60 think of the unsafe of OTCs during 
pregnancy but still took them with p=0.004. 
The results of taking heartburn OTCs and vitamin in relationship of safety are extremely 
close. Almost all women that think that OTCs are safe or unsafe have taken these 
medications during pregnancy, there is no relationship between thought of safety and 
taking gastrointestinal problems medications (P>0.05) but taking the vitamins has a 
relationship of thinking of the OTC’s safety (P<0.05). 
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Conclusion 
Ultimately, the relationship between age, BMI, level of education and the prevalence use 
of OTC medication during pregnancy is valid. The people on the higher economic and 
social status have a higher chance of making it through a pregnancy because of access to 
knowledge and facilities than those in the lower level. In addition to that, age and 
education level are the basic and fundamental factors that contribute to proper decision 
making by expectant mothers. 
The present study is the first in identifying predictors of OTC medications use in the 
Palestinian population. It has sought to find out the problems that are faced by pregnant 
women due to taking over the counter medication. The there is a clear lack of awareness on 
which medications to take and which ones to avoid during pregnancy. It shows that OTC’s 
medications may be harmful and can cause prematurity or mortality during pregnancy.   
The study has undertaken to find the relationship between age, socioeconomic, level of 
education and the use of OTC medication during pregnancy and birth issues.  It shows a 
relation between the use of OTC’s and age, BMI, the trimester of the pregnancy, smoking, 
physician and midwives visits and comorbidity but alcohol consumers did not show a 
relation with the prevalence use of OTC .  
A limitation for this study is that the self-reporting use of OTCs could lead to 
underestimation the prevalence of use, the woman may have used some herbal or drug and 
she think that is not OTC. Another limitation is that we could not reach to the all areas of 
Palestine; the results could be more valid if we include all urban and rural areas and more 
cities in the Palestinian authority. 
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Recommendations 
Results from this study will be presented at the National level and will be shared with the 
Health Care community and Palestinian Ministry of Health. Based on the results of this 
research recommendations are made on ways to help pregnant woman make better decision 
on the use of OTC medications during pregnancy. The study will has evaluated the role of 
health care professional in OTC medications during pregnancy. Thus the study 
recommends that: 
a. More government programs to be set to educate pregnant mothers on the issue of OTC 
consumption during pregnancy. 
b. The role of healthcare professionals such as pharmacists and physicians should be 
revaluated and incorporated to information provision. This is because mothers often 
look for information on the internet and colleagues. 
c. There should be laws that prohibit certain drugs to be sold to pregnant mothers because 
of their potential harm, unless recommended by doctors in very severe and serious 
cases. Ultimately, further research needs to be carried on the role that alternative 
sources of information in healthcare of expectant mothers. 
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Appendices 
 
Appendix 1 : English version of OTC Use in Pregnancy Questionnaire 
 
-- Current Pregnancy Trimester:   
 □ 1st (0-3 months)    □ 2nd (4-6 months)  □ 3rd (7-9 months)                 □ Other 
-- Have any healthcare professional prescribed you any drug (Prescription drugs) 
□ Yes   □ No 
-- If yes what is/are they________________________________________________ 
-- Have you taken any over-the-counter (OTC) medications during your current 
pregnancy? 
□ Yes   □ NO 
--  If yes, please list the medications you have used ______________ 
Is/they for_______ 
□ Pain, headache, or fever [like Paracetamol, Ibuprofen, Aspirin] 
other____________________ 
□ Cold, cough, or sore throat [nasal sprays, Lozenges, pseudoephedrine] 
other______________________ 
□ Heartburn or acid reflux [antacid, famotidine, ranitidine, omeprazole] 
other_____________ 
□ Constipation, diarrhea, or upset stomach [laxidin, lopremide] 
other_____________ 
□ Allergies [diphenhydramine, cetirizine, loratidine],  
other__________________ 
□ Over-the-counter vitamins (Vitamin D, Calcium, Prenatal Vitamin, folic acid.  
Any other OTC, herbal, vitamin medications __________________ 
--If you have used OTC medicines while pregnant, who recommended them? (circle all 
that apply) 
□ Physician/Doctor    □ Midwife/Nurse 
□ Pharmacist     □ I chose on my own. 
-- Where did you or have you gotten your information about the use of over-the-counter 
medications during your pregnancy? 
□ Physician  □ Midwife/nurse  □ Pharmacist   
□ Internet, Family and friends  □ Other_______________ 
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-- How safe do you think [OTC, Herbal, Vitamin]  are during pregnancy?  
□ Very safe, I don't need to talk to a healthcare professional before using.  
□ Safe, but I would talk to a healthcare professional before using.  
□ Safe, but I would check with resources, such as friends or the Internet, before using.  
□ Unsafe, I would not use these during pregnancy.  
 
-- Highest Level of Education:  
□ Less than high school    □ High school diploma 
□ College or technical degree    □ 4-year college degree 
□ Professional or graduate degree 
-- Age _______________ years old 
-- Residence    
□ Ramallah                    □  Nablus                      □ Hebron 
-- Smoking during pregnancy 
□ Smoker         □ Non-smoker  
-- Body max index__________________(kg/m2) 
-- Nullparity (7emlat wo nazalat wo ma 3endha awlad) 
□ Yes    □ No  
-- Gravidity (3adad el btoon ma3 elle nezlo) 
□ 1  □ 2  □ 3 or more  
-- Parity (3adad al-awlad) 
□ 0  □ 1  □ 2  □ 3  □ 4 or more 
-- General Practitioner visits 
□ 0                □ 1                       □ 2                   □3 or more 
-- Extra midwife visits 
□ 0                □ 1                       □  2         □       3 or more 
-- Miscarriage 
□   Yes    □ No 
-- Prematurity/mortality 
□  Yes                 □ No 
-- Alcohol consumption during pregnancy 
□ Yes               □  No 
-- Comorbidity (e.g. cardiac disease, lung disease and other chronic diseases) 
□ Yes                  □ No 
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Appendix 2: Arabic version of OTC Use in Pregnancy Questionnaire 
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Appendix 3 : Approval letter for Ministry of Health for the study 
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Appendix 4 : Cross Tablets and Chi-square testes. 
 AP4. Table 1: Relationship between age and taking (OTC) medications during current 
pregnancy. 
Age 
Have you taken any over-the-counter (OTC) 
medications during your current pregnancy? 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
Less than 20 94 24.0 68 41.5 162 29.2 
20-40 265 67.8 87 53.0 352 63.4 
40-60 32 8.2 9 5.5 41 7.4 
Total 391 100.0 164 100.0 555 100.0 
 
 
AP4. Table 2: Relationship between body max index and taking (OTC) medications during 
current pregnancy. 
BMI 
Have you taken any over-the-counter (OTC) 
medications during your current pregnancy? 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
<18.5 0 0.0 2 1.2 2 0.4 
18.5-24.9 81 20.7 112 68.3 193 34.8 
25-29.9 310 79.3 46 28.0 356 64.1 
>30 0 0.0 4 2.4 4 0.7 
Total 391 100.0 164 100.0 555 100.0 
 
Chi-Square Tests 
 Value Df Asymp. Sig. (2-sided) 
Pearson Chi-Square 136.793a 3 .000 
Likelihood Ratio 137.174 3 .000 
Linear-by-Linear Association 105.077 1 .000 
N of Valid Cases 555   
 
  
Chi-Square Tests 
 Value Df Asymp. Sig. (2-sided) 
Pearson Chi-Square 17.103
a 2 .000 
Likelihood Ratio 16.553 2 .000 
Linear-by-Linear Association 14.669 1 .000 
N of Valid Cases 555   
a. 0 cells (.0%) have expected frequency less than 5. The minimum expected frequency is 12.12. 
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AP4. Table 3: Relationship between highest level education and taking (OTC) medications 
during current pregnancy. 
Highest level of Education 
Have you taken any over-the-counter (OTC) 
medications during your current pregnancy? 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
Less than high school 102 26.1 69 42.1 171 30.8 
High school diploma 69 17.6 37 22.6 106 19.1 
College or technical degree 125 32.0 11 6.7 136 24.5 
4-year college degree 95 24.3 14 8.5 109 19.6 
Professional or graduate 
degree 
0 0.0 33 20.1 33 5.9 
Total 391 100.0 164 100.0 555 100.0 
 
 
 
Chi-Square Tests 
 
Value Df Asymp. Sig. (2-sided) 
Pearson Chi-Square 134.423
a
 4 .000 
Likelihood Ratio 145.993 4 .000 
Linear-by-Linear Association 1.098 1 .295 
N of Valid Cases 555   
a. 0 cells (.0%) have expected frequency less than 5. The minimum expected frequency is 9.75. 
 
AP4. Table  4 : Relationship between current pregnancy trimester and taking (OTC) 
medications during current pregnancy. 
Current 
Pregnancy 
Trimester 
Have you taken any over-the-counter 
(OTC) medications during your current 
pregnancy? 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
0-3 months 38 9.7 16 9.8 54 9.7 
4-6 months 195 49.9 1 0.6 196 35.3 
7-9 months 158 40.4 147 89.6 305 55.0 
Total 391 100.0 164 100.0 555 100.0 
  
 
Chi-Square Tests 
 Value Df Asymp. Sig. (2-sided) 
Pearson Chi-Square 130.339
a
 2 .000 
Likelihood Ratio 173.164 2 .000 
Linear-by-Linear Association 63.085 1 .000 
N of Valid Cases 555   
a. 0 cells (.0%) have expected frequency less than 5. The minimum expected frequency is 15.96. 
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AP4. Table 5: Relationship between miscarriage and taking (OTC) medications during 
current pregnancy. 
Miscarriage 
Have you taken any over-the-counter (OTC) 
medications during your current pregnancy? 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
Yes  157 40.2 37 22.6 194 35.0 
No 234 59.8 127 77.4 361 65.0 
Total 391 100.0 164 100.0 555 100.0 
 
Chi-Square Tests 
 
Value Df 
Asymp. Sig. 
(2-sided) 
Exact Sig. (2-
sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 15.727
a
 1 .000   
Continuity Correction
b
 14.963 1 .000   
Likelihood Ratio 16.453 1 .000   
Fisher's Exact Test    .000 .000 
Linear-by-Linear Association 15.699 1 .000   
N of Valid Cases 555     
a. 0 cells (.0%) have expected frequency less than 5. The minimum expected frequency is 57.33. 
b. Computed only for a 2x2 table 
 
AP4. Table 6: Relationship between prematurity or mortality and taking (OTC) medications 
during current pregnancy. 
Prematurity/ 
mortality 
Have you taken any over-the-counter (OTC) 
medications during your current pregnancy? 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
Yes  123 31.5 9 5.5 132 23.8 
No 268 68.5 155 94.5 423 76.2 
Total 391 100.0 164 100.0 555 100.0 
 
Chi-Square Tests 
 Value Df Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 42.988
a
 1 .000   
Continuity Correction
b
 41.567 1 .000   
Likelihood Ratio 52.211 1 .000   
isher's Exact Test    .000 .000 
Linear-by-Linear Association 42.910 1 .000   
N of Valid Cases 555     
a. 0 cells (.0%) have expected frequency less than 5. The minimum expected frequency is 39.01. 
b. Computed only for a 2x2 table 
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AP4. Table 7: Relationship between nullparity  and taking (OTC) medications during current 
pregnancy. 
 
Nullparity 
Have you taken any over-the-counter (OTC) 
medications during your current pregnancy? 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
Yes  58 14.8 0 0.0 58 10.5 
No 333 85.2 164 100.0 497 89.5 
Total 391 100.0 164 100.0 555 100.0 
  
Chi-Square Tests 
 
Value Df 
Asymp. Sig.  
(2-sided) 
Exact Sig.  
(2-sided) 
Exact Sig. 
 (1-sided) 
Pearson Chi-Square 27.166
a
 1 .000   
Continuity Correction
b
 25.604 1 .000   
Likelihood Ratio 43.410 1 .000   
Fisher's Exact Test    .000 .000 
Linear-by-Linear Association 27.117 1 .000   
N of Valid Cases 555     
a. 0 cells (.0%) have expected frequency less than 5. The minimum expected frequency is 17.14. 
b. Computed only for a 2x2 table 
 
AP4. Table 8 : Relationship between gravidity and taking (OTC) medications during current 
pregnancy. 
Gravidity 
Have you taken any over-the-counter (OTC) 
medications during your current pregnancy? 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
1 61 15.6 94 57.3 155 27.9 
2 106 27.1 0 0.0 106 19.1 
3 or more 224 57.3 70 42.7 294 53.0 
Total 391 100.0 164 100.0 555 100.0 
 
Chi-Square Tests 
 Value Df Asymp. Sig. (2-sided) 
Pearson Chi-Square 121.107
a
 2 .000 
Likelihood Ratio 143.235 2 .000 
Linear-by-Linear Association 49.023 1 .000 
N of Valid Cases 555   
a. 0 cells (.0%) have expected frequency less than 5. The minimum expected frequency is 31.32. 
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AP4. Table 9 : Relationship between parity and taking (OTC) medications during current 
pregnancy. 
Parity 
Have you taken any over-the-counter (OTC) 
medications during your current pregnancy? 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
0 79 20.2 2 1.2 81 14.6 
1 78 19.9 13 7.9 91 16.4 
2 96 24.6 43 26.2 139 25.0 
3 42 10.7 58 35.4 100 18.0 
4 or more 96 24.6 48 29.3 144 25.9 
Total 391 100.0 164 100.0 555 100.0 
 
Chi-Square Tests 
 Value Df Asymp. Sig. (2-sided) 
Pearson Chi-Square 78.718
a
 4 .000 
Likelihood Ratio 89.032 4 .000 
Linear-by-Linear Association 42.731 1 .000 
N of Valid Cases 555   
a. 0 cells (.0%) have expected frequency less than 5. The minimum expected 
frequency is 23.94. 
AP4. Table 10: Relationship between smoking and taking (OTC) medications during current 
pregnancy. 
Smoking 
during 
pregnancy 
Have you taken any over-the-counter (OTC) 
medications during your current pregnancy? 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
Yes  178 45.5 19 11.6 197 35.5 
No 213 54.5 145 88.4 358 64.5 
Total 391 100.0 164 100.0 555 100.0 
 
 
Chi-Square Tests 
 
Value Df 
Asymp. Sig. 
 (2-sided) 
Exact Sig.  
(2-sided) 
Exact Sig.  
(1-sided) 
Pearson Chi-Square 58.125
a
 1 .000   
Continuity Correction
b
 56.652 1 .000   
Likelihood Ratio 65.492 1 .000   
Fisher's Exact Test    .000 .000 
Linear-by-Linear Association 58.020 1 .000   
N of Valid Cases 555     
a. 0 cells (.0%) have expected frequency less than 5. The minimum expected frequency is 58.21. 
b. Computed only for a 2x2 table 
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AP4. Table 11: Relationship between alcohol consumption and taking (OTC) medications 
during current pregnancy. 
Alcohol 
consumption 
during 
pregnancy 
Have you taken any over-the-counter (OTC) 
medications during your current pregnancy? 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
Yes  4 1.0 2 1.2 6 1.1 
No 387 99.0 162 98.8 549 98.9 
Total 391 100.0 164 100.0 555 100.0 
 
Chi-Square Tests 
 
Value Df 
Asymp. Sig. 
(2-sided) 
Exact Sig.  
(2-sided) 
Exact Sig.  
(1-sided) 
Pearson Chi-Square .042
a
 1 .838   
Continuity Correction
b
 .000 1 1.000   
Likelihood Ratio .041 1 .840   
Fisher's Exact Test    1.000 .571 
Linear-by-Linear Association .042 1 .838   
N of Valid Cases 555     
a. 2 cells (50.0%) have expected frequency less than 5. The minimum expected frequency is 1.77. 
b. Computed only for a 2x2 table 
 
AP4. Table 12: Relationship between general practitioner visits and taking (OTC) 
medications during current pregnancy. 
General 
Practitioner visits 
Have you taken any over-the-counter (OTC) 
medications during your current pregnancy? 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
0 0 0.0 29 17.7 29 5.2 
1 46 11.8 7 4.3 53 9.5 
2 45 11.5 100 61.0 145 26.1 
3 or more 300 76.7 28 17.1 328 59.1 
Total 391 100.0 164 100.0 555 100.0 
 
Chi-Square Tests 
 Value Df Asymp. Sig. (2-sided) 
Pearson Chi-Square 253.721
a
 3 .000 
Likelihood Ratio 261.433 3 .000 
Linear-by-Linear Association 118.965 1 .000 
N of Valid Cases 555   
a. 0 cells (.0%) have expected frequency less than 5. The minimum expected 
frequency is 8.57. 
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AP4. Table 13: Relationship between extra midwife visits and taking (OTC) medications 
during current pregnancy. 
 
Extra midwife 
visits 
Have you taken any over-the-counter (OTC) 
medications during your current pregnancy? 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
0 345 88.2 15 9.1 360 64.9 
1 10 2.6 41 25.0 51 9.2 
2 0 0.0 22 13.4 22 4.0 
3 or more 36 9.2 86 52.4 122 22.0 
Total 391 100.0 164 100.0 555 100.0 
 
Chi-Square Tests 
 Value Df Asymp. Sig. (2-sided) 
Pearson Chi-Square 325.431
a
 3 .000 
Likelihood Ratio 350.560 3 .000 
Linear-by-Linear Association 240.042 1 .000 
N of Valid Cases 555   
a. 0 cells (.0%) have expected frequency less than 5. The minimum expected frequency is 6.50. 
 
AP4. Table 14: Relationship between comorbidity (e.g. cardiac disease, lung disease and 
other chronic diseases) and taking (OTC) medications during current pregnancy. 
Comorbidity (e.g. 
cardiac disease, 
lung disease and 
other chronic 
diseases) 
Have you taken any over-the-counter (OTC) 
medications during your current pregnancy? 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
Yes  25 6.4 46 28.0 71 12.8 
No 366 93.6 118 72.0 484 87.2 
Total 391 100.0 164 100.0 555 100.0 
 
 
Chi-Square Tests 
 
Value Df 
Asymp. Sig. 
(2-sided) 
Exact Sig.  
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 48.565
a
 1 .000   
Continuity Correction
b
 46.643 1 .000   
Likelihood Ratio 43.998 1 .000   
Fisher's Exact Test    .000 .000 
Linear-by-Linear Association 48.477 1 .000   
N of Valid Cases 555     
a. 0 cells (.0%) have expected frequency less than 5. The minimum expected frequency is 20.98. 
b. Computed only for a 2x2 table 
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AP4. Table 15: Relationship between prescribed drugs by healthcare professional and taking 
(OTC) medications during current pregnancy. 
Have any 
healthcare 
professional 
prescribed you any 
drug (Prescription 
drugs) 
Have you taken any over-the-counter (OTC) 
medications during your current pregnancy? 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
Yes  197 50.4 54 32.9 251 45.2 
No 194 49.6 110 67.1 304 54.8 
Total 391 100.0 164 100.0 555 100.0 
 
Chi-Square Tests 
 
Value Df 
Asymp. Sig.  
(2-sided) 
Exact Sig.  
(2-sided) 
Exact Sig.  
(1-sided) 
Pearson Chi-Square 14.213
a
 1 .000   
Continuity Correction
b
 13.517 1 .000   
Likelihood Ratio 14.466 1 .000   
Fisher's Exact Test    .000 .000 
Linear-by-Linear Association 14.188 1 .000   
N of Valid Cases 555     
a. 0 cells (.0%) have expected frequency less than 5. The minimum expected frequency is 74.17. 
b. Computed only for a 2x2 table 
 
AP4. Table 16: Relationship between the number of prescribed drugs and taking (OTC) 
medications during current pregnancy. 
If yes what is/are 
they_________ 
Have you taken any over-the-counter (OTC) 
medications during your current pregnancy? 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
 1 126 64.0 54 100.0 180 71.7 
2 71 36.0 0 0.0 71 28.3 
Total 197 100.0 54 100.0 251 100.0 
 
Chi-Square Tests 
 
Value Df 
Asymp. Sig. 
(2-sided) 
Exact Sig.  
(2-sided) 
Exact Sig.  
(1-sided) 
Pearson Chi-Square 27.139
a
 1 .000   
Continuity Correction
b
 25.391 1 .000   
Likelihood Ratio 41.474 1 .000   
Fisher's Exact Test    .000 .000 
Linear-by-Linear Association 27.030 1 .000   
N of Valid Cases 251     
a. 0 cells (.0%) have expected frequency less than 5. The minimum expected frequency is 15.27. 
b. Computed only for a 2x2 table 
 
 55 
AP4. Table 17: Distribution of the healthcare professional recommended OTC medication. 
 
)%( Frequency Who recommended OTC? 
82.6 323 Physician / Doctor 
12.3 48 Midwife/Nurse 
1.0 4 Pharmacist 
4.1 16 I chose on my own 
100.0 391 Total 
 
Chi-Square Tests 
 Value 
Pearson Chi-Square .
a
 
N of Valid Cases 391 
a. No statistics are computed because Have you taken any over-the-counter (OTC) medications 
during your current pregnancy? is a constant. 
 
AP4. Table 18: Where did you or have you gotten your information about the use of over-the-
counter medications during your pregnancy * Have you taken any over-the-Counter  (OTC) 
medications during your current pregnancy? 
)%( Frequency 
Where did you or have you gotten 
your information about the use of 
over-the-counter medications during 
your pregnancy 
9.2 36 Physician / Doctor 
0.8 3 Midwife/Nurse 
83.1 325 Pharmacist 
6.9 27 Internet, Family and friends 
100.0 391 Total 
 
Chi-Square Tests 
 Value 
Pearson Chi-Square .
a
 
N of Valid Cases 391 
a. No statistics are computed because Have you taken any over-the-counter (OTC) medications 
during your current pregnancy? is a constant. 
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AP4. Table 19: Relationship between taking paracetamol, Ibuprofen or aspirin during 
pregnancy and miscarriage occurrence. 
Paracetamol, 
Ibuprofen and 
aspirin 
Miscarriage 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
Yes  67 42.7 116 49.6 183 46.8 
No 90 57.3 118 50.4 208 53.2 
Total 157 100.0 234 100.0 391 100.0 
 
Chi-Square Tests 
 
Value Df 
Asymp. Sig. 
(2-sided) 
Exact Sig.  
(2-sided) 
Exact Sig.  
1-sided) 
Pearson Chi-Square 1.795
a
 1 .180   
Continuity Correction
b
 1.529 1 .216   
Likelihood Ratio 1.799 1 .180   
Fisher's Exact Test    .215 .108 
Linear-by-Linear 
Association 
1.791 1 .181 
  
N of Valid Cases 391 
    
a. 0 cells (.0%) have expected frequency less than 5. The minimum expected frequency is 73.48. 
b. Computed only for a 2x2 table 
AP4. Table 20: Relationship between taking cold, cough, or sore throat [nasal sprays, 
Lozenges, pseudoephedrine]during pregnancy and miscarriage occurrence. 
Cold, cough, or sore 
throat [nasal sprays, 
Lozenges, 
pseudoephedrine] 
Miscarriage 
Total Yes No 
Frequency 
(%) Frequency (%) Frequency (%) 
Yes  3 1.9 6 2.6 9 2.3 
No 154 98.1 228 97.4 382 97.7 
Total 157 100.0 234 100.0 391 100.0 
 
 
Chi-Square Tests 
 
Value Df 
Asymp. Sig.  
(2-sided) 
Exact Sig.  
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square .178
a
 1 .673   
Continuity Correction
b
 .006 1 .938   
Likelihood Ratio .182 1 .669   
Fisher's Exact Test    .746 .478 
Linear-by-Linear Association .178 1 .673   
N of Valid Cases 391     
a. 1 Cells (25.0%) have expected frequency less than 5. The minimum expected frequency is 3.61. 
b. Computed only for a 2x2 table 
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AP4. Table 21: Relationship between heartburn or acid reflux drugs [antacid, famotidine, 
ranitidine, omeprazole] during pregnancy and miscarriage occurrence. 
Heartburn or acid 
reflux [antacid, 
famotidine, 
ranitidine, 
omeprazole] 
Miscarriage 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
Yes  154 98.1 228 97.4 382 97.7 
No 3 1.9 6 2.6 9 2.3 
Total 157 100.0 234 100.0 391 100.0 
 
Chi-Square Tests 
 
Value Df 
Asymp. Sig.  
(2-sided) 
Exact Sig.  
(2-sided) 
Exact Sig.  
(1-sided) 
Pearson Chi-Square .178
a
 1 .673   
Continuity Correction
b
 .006 1 .938   
Likelihood Ratio .182 1 .669   
Fisher's Exact Test    .746 .478 
Linear-by-Linear Association .178 1 .673   
N of Valid Cases 391     
a. 1 Cells (25.0%) have expected frequency less than 5. The minimum expected Frequency is 3.61. 
b. Computed only for a 2x2 table 
 
AP4. Table 22: Relationship between Constipation, diarrhea, or upset stomach drugs [laxidin, 
lopremide] during pregnancy and miscarriage occurrence. 
Constipation, 
diarrhea, or upset 
stomach [laxidin, 
lopremide] 
Miscarriage 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
Yes  6 3.8 29 12.4 35 9.0 
No 151 96.2 205 87.6 356 91.0 
Total 157 100.0 234 100.0 391 100.0 
 
Chi-Square Tests 
 
Value Df 
Asymp. Sig. 
(2-sided) 
Exact Sig.  
(2-sided) 
Exact Sig.  
(1-sided) 
Pearson Chi-Square 8.470
a
 1 .004   
Continuity Correction
b
 7.451 1 .006   
Likelihood Ratio 9.410 1 .002   
Fisher's Exact Test    .003 .002 
Linear-by-Linear Association 8.448 1 .004   
N of Valid Cases 391     
a. 0 cells (.0%) have expected frequency less than 5. The minimum expected frequency is 14.05. 
b. Computed only for a 2x2 table 
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AP4. Table 23: Relationship between allergies drugs [[diphenhydramine, cetirizine, 
loratidine] during pregnancy and miscarriage occurrence. 
Allergies 
[diphenhydramine, 
cetirizine, loratidine] 
Miscarriage 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
Yes  1 0.6 3 1.3 4 1.0 
No 156 99.4 231 98.7 387 99.0 
Total 157 100.0 234 100.0 391 100.0 
 
Chi-Square Tests 
 
Value Df 
Asymp. Sig. 
 (2-sided) 
Exact Sig.  
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square .386
a
 1 .534   
Continuity Correction
b
 .012 1 .913   
Likelihood Ratio .411 1 .522   
Fisher's Exact Test    .652 .472 
Linear-by-Linear 
Association 
.385 1 .535 
  
N of Valid Cases 391     
a. 2 cells (50.0%) have expected frequency less than 5. The minimum expected frequency is 1.61. 
b. Computed only for a 2x2 table 
AP4. Table 24: Relationship between Over-the-counter vitamins (vitamin D, calcium, 
prenatal vitamin, folic acid) during pregnancy and miscarriage occurrence. 
Over-the-counter 
vitamins (Vitamin D, 
Calcium, Prenatal 
Vitamin, folic acid) 
Miscarriage 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
Yes  154 98.1 229 97.9 383 98.0 
No 3 1.9 5 2.1 8 2.0 
Total 157 100.0 234 100.0 391 100.0 
 
 
Chi-Square Tests 
 
Value Df 
Asymp. Sig. 
(2-sided) 
Exact Sig.  
(2-sided) 
Exact Sig.  
(1-sided) 
Pearson Chi-Square .024
a
 1 .877   
Continuity Correction
b
 .000 1 1.000   
Likelihood Ratio .024 1 .877   
Fisher's Exact Test    1.000 .591 
Linear-by-Linear Association .024 1 .877   
N of Valid Cases 391     
a. 2 cells (50.0%) have expected frequency less than 5. The minimum expected frequency is 3.21. 
b. Computed only for a 2x2 table 
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AP4 . Table 25 : Relationship between taking paracetamol, ibuprofen or aspirin during 
pregnancy and prematurity or mortality occurrence. 
Paracetamol, 
ibuprofen, aspirin 
Prematurity/mortality 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
Yes  10 8.1 173 64.6 183 46.8 
No 113 91.9 95 35.4 208 53.2 
Total 123 100.0 268 100.0 391 100.0 
 
Chi-Square Tests 
 
Value Df 
Asymp. Sig.  
(2-sided) 
Exact Sig. 
 (2-sided) 
Exact Sig.  
(1-sided) 
Pearson Chi-Square 107.796
a
 1 .000   
Continuity Correction
b
 105.542 1 .000   
Likelihood Ratio 122.592 1 .000   
Fisher's Exact Test    .000 .000 
Linear-by-Linear Association 107.520 1 .000   
N of Valid Cases 391     
a. 0 cells (.0%) have expected Frequency less than 5. The minimum expected Frequency is 57.57. 
b. Computed only for a 2x2 table 
 
AP4. Table 26: Relationship between taking Cold, cough, or sore throat drugs [nasal sprays, 
Lozenges, pseudoephedrine] during pregnancy and prematurity or mortality occurrence. 
Cold, cough, or sore 
throat [nasal sprays, 
Lozenges, 
pseudoephedrine] 
Prematurity/mortality 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
Yes  0 0.0 9 3.4 9 2.3 
No 123 100.0 259 96.6 382 97.7 
Total 123 100.0 268 100.0 391 100.0 
 
Chi-Square Tests 
 
Value Df 
Asymp. Sig.  
(2-sided) 
Exact Sig. 
 (2-sided) 
Exact Sig.  
(1-sided) 
Pearson Chi-Square 4.228
a
 1 .040   
Continuity Correction
b
 2.866 1 .090   
Likelihood Ratio 6.896 1 .009   
Fisher's Exact Test    .062 .032 
Linear-by-Linear Association 4.217 1 .040   
N of Valid Cases 391     
a. 1 cells (25.0%) have expected Frequency less than 5. The minimum expected Frequency is 2.83. 
b. Computed only for a 2x2 table 
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AP4. Table 27: Relationship between taking heartburn or acid reflux drugs [antacid, 
famotidine, ranitidine, omeprazole] during pregnancy and prematurity or mortality 
occurrence. 
Heartburn or acid 
reflux [antacid, 
famotidine, 
ranitidine, 
omeprazole] 
Prematurity/mortality 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
Yes  114 92.7 268 100.0 382 97.7 
No 9 7.3 0 0.0 9 2.3 
Total 123 100.0 268 100.0 391 100.0 
 
Chi-Square Tests 
 
Value Df 
Asymp. Sig. 
(2-sided) 
Exact Sig.  
(2-sided) 
Exact Sig. 
 (1-sided) 
Pearson Chi-Square 20.072
a
 1 .000   
Continuity Correction
b
 16.950 1 .000   
Likelihood Ratio 21.284 1 .000   
Fisher's Exact Test    .000 .000 
Linear-by-Linear 
Association 
20.020 1 .000 
  
N of Valid Cases 391     
a. 1 cells (25.0%) have expected frequency less than 5. The minimum expected frequency is 2.83. 
b. Computed only for a 2x2 table 
 
AP4. Table 28: Relationship between taking constipation, diarrhea, or upset stomach drugs 
[laxidin, lopremide] during pregnancy and prematurity or mortality occurrence. 
Constipation, 
diarrhea, or upset 
stomach [laxidin, 
lopremide] 
Prematurity/mortality 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
Yes  0 0.0 35 13.1 35 9.0 
No 123 100.0 233 86.9 356 91.0 
Total 123 100.0 268 100.0 391 100.0 
 
Chi-Square Tests 
 
Value Df 
Asymp. Sig. 
 (2-sided) 
Exact Sig.  
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 17.643
a
 1 .000   
Continuity Correction
b
 16.077 1 .000   
Likelihood Ratio 27.994 1 .000   
Fisher's Exact Test    .000 .000 
Linear-by-Linear Association 17.598 1 .000   
N of Valid Cases 391     
a. 0 cells (.0%) have expected frequency less than 5. The minimum expected frequency is 11.01. 
b. Computed only for a 2x2 table 
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AP4. Table 29: Relationship between taking allergies drugs [diphenhydramine, cetirizine, 
loratidine] during pregnancy and prematurity or mortality occurrence. 
Allergies 
[diphenhydramine, 
cetirizine, 
loratidine] 
Prematurity/mortality 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
Yes  4 3.3 0 0.0 4 1.0 
No 119 96.7 268 100.0 387 99.0 
Total 123 100.0 268 100.0 391 100.0 
 
Chi-Square Tests 
 
Value Df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
 (2-sided) 
Exact Sig.  
(1-sided) 
Pearson Chi-Square 8.806
a
 1 .003   
Continuity Correction
b
 5.887 1 .015   
Likelihood Ratio 9.343 1 .002   
Fisher's Exact Test    .009 .009 
Linear-by-Linear Association 8.783 1 .003   
N of Valid Cases 391     
a. 2 cells (50.0%) have expected frequency less than 5. The minimum expected frequency is 1.26. 
b. Computed only for a 2x2 table 
 
AP4. Table 30: Relationship between taking over-the-counter vitamins (vitamin D, calcium, 
prenatal vitamin, folic acid) during pregnancy and prematurity or mortality occurrence. 
Over-the-counter 
vitamins (Vitamin D, 
Calcium, Prenatal 
Vitamin, folic acid) 
Prematurity/mortality 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
Yes  123 100.0 260 97.0 383 98.0 
No 0 0.0 8 3.0 8 2.0 
Total 123 100.0 268 100.0 391 100.0 
 
 
 
Chi-Square Tests 
 
Value Df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
 (2-sided) 
Exact Sig. 
 (1-sided) 
Pearson Chi-Square 3.748
a
 1 .053   
Continuity Correction
b
 2.407 1 .121   
Likelihood Ratio 6.120 1 .013   
Fisher's Exact Test    .061 .047 
Linear-by-Linear Association 3.739 1 .053   
N of Valid Cases 391     
a. 1 cells (25.0%) have expected frequency less than 5. The minimum expected frequency is 2.52. 
b. Computed only for a 2x2 table 
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AP4. Table 31: Relationship between taking paracetamol, ibuprofen or aspirin during 
pregnancy and Nullparity. 
Paracetamol, 
ibuprofen, aspirin 
Nullparity 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
Yes  32 55.2 151 45.3 183 46.8 
No 26 44.8 182 54.7 208 53.2 
Total 58 100.0 333 100.0 391 100.0 
 
Chi-Square Tests 
 
Value Df 
Asymp. Sig.  
(2-sided) 
Exact Sig. 
 (2-sided) 
Exact Sig.  
(1-sided) 
Pearson Chi-Square 1.916
a
 1 .166   
Continuity Correction
b
 1.542 1 .214   
Likelihood Ratio 1.912 1 .167   
Fisher's Exact Test    .199 .107 
Linear-by-Linear Association 1.911 1 .167   
N of Valid Cases 391     
a. 0 cells (.0%) have expected frequency less than 5. The minimum expected frequency is 27.15. 
b. Computed only for a 2x2 table 
 
AP4. Table 32: Relationship between taking Cold, cough, or sore throat drugs [nasal sprays, 
Lozenges, pseudoephedrine] during pregnancy and Nullparity. 
Cold, cough, or sore 
throat [nasal sprays, 
Lozenges, 
pseudoephedrine] 
Nullparity 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
Yes  2 3.4 7 2.1 9 2.3 
No 56 96.6 326 97.9 382 97.7 
Total 58 100.0 333 100.0 391 100.0 
 
Chi-Square Tests 
 
Value Df 
Asymp. Sig.  
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square .398
a
 1 .528   
Continuity Correction
b
 .024 1 .876   
Likelihood Ratio .355 1 .551   
Fisher's Exact Test    .628 .396 
Linear-by-Linear Association .397 1 .529   
N of Valid Cases 391     
a. 1 Cells (25.0%) have expected frequency less than 5. The minimum expected frequency is 1.34. 
b. Computed only for a 2x2 table 
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AP4. Table 33: Relationship between taking heartburn or acid reflux drugs [antacid, 
famotidine, ranitidine, omeprazole] during pregnancy and Nullparity. 
Heartburn or acid 
reflux [antacid, 
famotidine, 
ranitidine, 
omeprazole] 
Nullparity 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
Yes  55 94.8 327 98.2 382 97.7 
No 3 5.2 6 1.8 9 2.3 
Total 58 100.0 333 100.0 391 100.0 
 
Chi-Square Tests 
 
Value Df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
 (2-sided) 
Exact Sig.  
(1-sided) 
Pearson Chi-Square 2.496
a
 1 .114   
Continuity Correction
b
 1.222 1 .269   
Likelihood Ratio 1.977 1 .160   
Fisher's Exact Test    .135 .135 
Linear-by-Linear Association 2.489 1 .115   
N of Valid Cases 391     
a. 1 cells (25.0%) have expected frequency less than 5. The minimum expected frequency is 1.34. 
b. Computed only for a 2x2 table 
 
AP4. Table 34: Relationship between taking constipation, diarrhea, or upset stomach drugs 
[laxidin, lopremide] during pregnancy and Nullparity. 
Constipation, 
diarrhea, or upset 
stomach [laxidin, 
lopremide] 
Nullparity 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
Yes  5 8.6 30 9.0 35 9.0 
No 53 91.4 303 91.0 356 91.0 
Total 58 100.0 333 100.0 391 100.0 
 
Chi-Square Tests 
 
Value Df 
Asymp. Sig. 
 (2-sided) 
Exact Sig. 
 (2-sided) 
Exact Sig.  
(1-sided) 
Pearson Chi-Square .009
a
 1 .924   
Continuity Correction
b
 .000 1 1.000   
Likelihood Ratio .009 1 .923   
Fisher's Exact Test    1.000 .580 
Linear-by-Linear 
Association 
.009 1 .924 
  
N of Valid Cases 391     
a. 0 cells (.0%) have expected frequency less than 5. The minimum expected frequency is 5.19. 
b. Computed only for a 2x2 table 
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AP4. Table 35: Relationship between taking allergies drugs [diphenhydramine, cetirizine, 
loratidine] during pregnancy and Nullparity. 
Allergies 
[diphenhydramine, 
cetirizine, loratidine] 
Nullparity 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
Yes  0 0.0 4 1.2 4 1.0 
No 58 100.0 329 98.8 387 99.0 
Total 58 100.0 333 100.0 391 100.0 
 
Chi-Square Tests 
 
Value Df 
Asymp. Sig. 
 (2-sided) 
Exact Sig.  
(2-sided) 
Exact Sig.  
(1-sided) 
Pearson Chi-Square .704
a
 1 .401   
Continuity Correction
b
 .017 1 .895   
Likelihood Ratio 1.292 1 .256   
Fisher's Exact Test    1.000 .525 
Linear-by-Linear Association .702 1 .402   
N of Valid Cases 391     
a. 2 cells (50.0%) have expected frequency less than 5. The minimum expected frequency is .59. 
b. Computed only for a 2x2 table 
 
AP4. Table 36: Relationship between taking over-the-counter vitamins (vitamin D, calcium, 
prenatal vitamin, folic acid) during pregnancy and Nullparity. 
Over-the-counter 
vitamins (Vitamin D, 
Calcium, Prenatal 
Vitamin, folic acid) 
Nullparity 
Total Yes No 
Frequency (%) Frequency (%) Frequency (%) 
Yes  56 96.6 327 98.2 383 98.0 
No 2 3.4 6 1.8 8 2.0 
Total 58 100.0 333 100.0 391 100.0 
 
Chi-Square Tests 
 
Value Df 
Asymp. Sig.  
(2-sided) 
Exact Sig.  
(2-sided) 
Exact Sig.  
(1-sided) 
Pearson Chi-Square .668
a
 1 .414   
Continuity Correction
b
 .099 1 .753   
Likelihood Ratio .576 1 .448   
Fisher's Exact Test    .338 .338 
Linear-by-Linear Association .666 1 .414   
N of Valid Cases 391     
a. 1 Cells (25.0%) have expected frequency less than 5. The minimum expected frequency is 1.19. 
b. Computed only for a 2x2 table 
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AP4. Table 37: Relationship between taking paracetamol, ibuprofen or aspirin during 
pregnancy and Gravidity. 
Paracetamo, 
ibuprofen, 
aspirin 
Gravidity 
Total 1 2 3 or more 
Frequency (%) Frequency (%) Frequency (%) Frequency (%) 
Yes  54 88.5 35 33.0 94 42.0 183 46.8 
No 7 11.5 71 67.0 130 58.0 208 53.2 
Total 61 100.0 106 100.0 224 100.0 391 100.0 
 
Chi-Square Tests 
 Value Df Asymp. Sig. (2-sided) 
Pearson Chi-Square 52.843
a
 2 .000 
Likelihood Ratio 57.775 2 .000 
Linear-by-Linear Association 24.306 1 .000 
N of Valid Cases 391   
a. 0 Cells (.0%) have expected frequency less than 5. The minimum expected frequency is 28.55. 
 
AP4. Table 38: Relationship between taking cold, cough, or sore throat drugs [nasal sprays, 
Lozenges, pseudoephedrine] during pregnancy and Gravidity. 
Cold, cough, or 
sore throat 
[nasal sprays, 
Lozenges, 
pseudoephedrine
] 
Gravidity 
Total 1 2 3 or more 
Frequen
cy 
(%) Frequency (%) Frequency (%) Frequency (%) 
Yes  5 8.2 0 0.0 4 1.8 9 2.3 
No 56 91.8 106 100.0 220 98.2 382 97.7 
Total 61 100.0 106 100.0 224 100.0 391 100.0 
 
Chi-Square Tests 
 Value Df Asymp. Sig. (2-sided) 
Pearson Chi-Square 12.189
a
 2 .002 
Likelihood Ratio 10.954 2 .004 
Linear-by-Linear Association 4.614 1 .032 
N of Valid Cases 391   
a. 2 Cells (33.3%) have expected frequency less than 5. The minimum expected 
frequency is 1.40. 
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AP4. Table 39: Relationship between taking heartburn or acid reflux drugs [antacid, 
famotidine, ranitidine, omeprazole] during pregnancy and Gravidity. 
Heartburn or 
acid reflux 
[antacid, 
famotidine, 
ranitidine, 
omeprazole] 
Gravidity 
Total 1 2 3 or more 
Frequency (%) Frequency (%) Frequency (%) Frequency (%) 
Yes  59 96.7 104 98.1 219 97.8 382 97.7 
No 2 3.3 2 1.9 5 2.2 9 2.3 
Total 61 100.0 106 100.0 224 100.0 391 100.0 
 
Chi-Square Tests 
 Value Df Asymp. Sig. (2-sided) 
Pearson Chi-Square .345
a
 2 .842 
Likelihood Ratio .320 2 .852 
Linear-by-Linear Association .116 1 .734 
N of Valid Cases 391   
a. 2 Cells (33.3%) have expected Frequency less than 5. The minimum expected Frequency is 1.40. 
 
AP4. Table 40: Relationship between taking constipation, diarrhea, or upset stomach drugs 
[laxidin, lopremide] during pregnancy and Gravidity. 
Constipation, 
diarrhea, or 
upset stomach 
[laxidin, 
lopremide] 
Gravidity 
Total 1 2 3 or more 
Frequency (%) Frequency (%) Frequency (%) Frequency (%) 
Yes  18 29.5 0 0.0 17 7.6 35 9.0 
No 43 70.5 106 100.0 207 92.4 356 91.0 
Total 61 100.0 106 100.0 224 100.0 391 100.0 
 
Chi-Square Tests 
 Value Df Asymp. Sig. (2-sided) 
Pearson Chi-Square 42.560
a
 2 .000 
Likelihood Ratio 41.352 2 .000 
Linear-by-Linear Association 13.706 1 .000 
N of Valid Cases 391   
a. 0 Cells (.0%) have expected frequency less than 5. The minimum expected frequency is 5.46. 
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AP4. Table 41: Relationship between taking allergies drugs [diphenhydramine, cetirizine, 
loratidine] during pregnancy and Gravidity. 
Allergies 
[diphenhydram
ine, cetirizine, 
loratidine] 
Gravidity 
Total 1 2 3 or more 
Frequency (%) Frequency (%) Frequency (%) Frequency (%) 
Yes  0 0.0 2 1.9 2 0.9 4 1.0 
No 61 100.0 104 98.1 222 99.1 387 99.0 
Total 61 100.0 106 100.0 224 100.0 391 100.0 
 
Chi-Square Tests 
 Value Df Asymp. Sig. (2-sided) 
Pearson Chi-Square 1.449
a
 2 .485 
Likelihood Ratio 1.919 2 .383 
Linear-by-Linear Association .050 1 .823 
N of Valid Cases 391   
a. 3 Cells (50.0%) have expected frequency less than 5. The minimum expected frequency is .62. 
 
AP4. Table 42: Relationship between taking over-the-counter vitamins (vitamin D, calcium, 
prenatal vitamin, folic acid) during pregnancy and Gravidity. 
Over-the-counter 
vitamins (Vitamin 
D, Calcium, 
Prenatal Vitamin, 
folic acid) 
Gravidity 
Total 1 2 3 or more 
Frequency (%) Frequency (%) Frequency (%) Frequency (%) 
Yes  56 91.8 106 100.0 221 98.7 383 98.0 
No 5 8.2 0 0.0 3 1.3 8 2.0 
Total 61 100.0 106 100.0 224 100.0 391 100.0 
 
Chi-Square Tests 
 Value Df Asymp. Sig. (2-sided) 
Pearson Chi-Square 14.287
a
 2 .001 
Likelihood Ratio 11.633 2 .003 
Linear-by-Linear Association 6.526 1 .011 
N of Valid Cases 391   
a. 3 Cells (50.0%) have expected frequency less than 5. The minimum expected frequency is 1.25. 
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AP4. Table 43: Relationship between taking paracetamol, ibuprofen or aspirin during 
pregnancy and the thought of how safe [OTC, Herbal, Vitamin] are during pregnancy. 
Paracetamol, 
ibuprofen, 
aspirin 
How safe do you think [OTC, Herbal, Vitamin] are during 
pregnancy? 
Total 
Safe, but I would 
talk to a healthcare 
professional before 
using 
Safe, but I would 
check with 
resources, such as 
friends or the 
Internet, before 
using 
Unsafe, I would not 
use these during 
pregnancy. 
Frequency (%) Frequency (%) Frequency (%) Frequency (%) 
Yes  112 54.6 11 44.0 60 37.3 183 46.8 
No 93 45.4 14 56.0 101 62.7 208 53.2 
Total 205 100.0 25 100.0 161 100.0 391 100.0 
 
Chi-Square Tests 
 Value Df Asymp. Sig. (2-sided) 
Pearson Chi-Square 11.009
a
 2 .004 
Likelihood Ratio 11.082 2 .004 
Linear-by-Linear Association 10.945 1 .001 
N of Valid Cases 391   
a. 0 Cells (.0%) have expected frequency less than 5. The minimum expected frequency is 11.70. 
 
AP4. Table 44: Relationship between taking cold, cough, or sore throat drugs [nasal sprays, 
Lozenges, pseudoephedrine] during pregnancy and the thought of how safe [OTC, Herbal, 
Vitamin] are during pregnancy.  
Cold, cough, or 
sore throat [nasal 
sprays, Lozenges, 
pseudoephedrine] 
How safe do you think [OTC, Herbal, Vitamin]  are during 
pregnancy? 
Total 
Safe, but I would 
talk to a healthcare 
professional before 
using 
Safe, but I would 
check with 
resources, such as 
friends or the 
Internet, before 
using 
Unsafe, I would not 
use these during 
pregnancy. 
Frequency (%) Frequency (%) Frequency (%) Frequency (%) 
Yes  9 4.4 0 0.0 0 0.0 9 2.3 
No 196 95.6 25 100.0 161 100.0 382 97.7 
Total 205 100.0 25 100.0 161 100.0 391 100.0 
 
Chi-Square Tests 
 Value Df Asymp. Sig. (2-sided) 
Pearson Chi-Square 8.358
a
 2 .015 
Likelihood Ratio 11.815 2 .003 
Linear-by-Linear Association 7.837 1 .005 
N of Valid Cases 391   
a. 3 Cells (50.0%) have expected frequency less than 5. The minimum expected frequency is .58. 
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AP4. Table 45 : Relationship between taking heartburn or acid reflux drugs [antacid, 
famotidine, ranitidine, omeprazole] during pregnancy and the thought of how safe [OTC, 
Herbal, Vitamin] are during pregnancy.   
Heartburn or 
acid reflux 
[antacid, 
famotidine, 
ranitidine, 
omeprazole] 
How safe do you think [OTC, Herbal, Vitamin]  are during 
pregnancy? 
Total 
Safe, but I would 
talk to a 
healthcare 
professional 
before using 
Safe, but I would 
check with 
resources, such as 
friends or the 
Internet, before 
using 
Unsafe, I would 
not use these 
during pregnancy. 
Frequency (%) Frequency (%) Frequency (%) Frequency (%) 
Yes  198 96.6 25 100.0 159 98.8 382 97.7 
No 7 3.4 0 0.0 2 1.2 9 2.3 
Total 205 100.0 25 100.0 161 100.0 391 100.0 
 
Chi-Square Tests 
 Value Df Asymp. Sig. (2-sided) 
Pearson Chi-Square 2.522
a
 2 .283 
Likelihood Ratio 3.112 2 .211 
Linear-by-Linear Association 1.953 1 .162 
N of Valid Cases 391   
a. 3 Cells (50.0%) have expected frequency less than 5. The minimum expected frequency is .58. 
 
AP4. Table 46: Relationship between taking constipation, diarrhea, or upset stomach drugs 
[laxidin, lopremide] during pregnancy and the thought of how safe [OTC, Herbal, Vitamin] 
are during pregnancy.   
Constipatio
n, diarrhea, 
or upset 
stomach 
[laxidin, 
lopremide] 
How safe do you think [OTC, Herbal, Vitamin]  are during 
pregnancy? 
Total 
Safe, but I would 
talk to a healthcare 
professional before 
using 
Safe, but I would 
check with resources, 
such as friends or the 
Internet, before using 
Unsafe, I would 
not use these 
during pregnancy. 
Frequency (%) Frequency (%) Frequency (%) Frequency (%) 
Yes  35 17.1 0 0.0 0 0.0 35 9.0 
No 170 82.9 25 100.0 161 100.0 356 91.0 
Total 205 100.0 25 100.0 161 100.0 391 100.0 
 
Chi-Square Tests 
 Value Df Asymp. Sig. (2-sided) 
Pearson Chi-Square 34.878
a
 2 .000 
Likelihood Ratio 48.316 2 .000 
Linear-by-Linear Association 32.704 1 .000 
N of Valid Cases 391   
a. 1 Cells (16.7%) have expected frequency less than 5. The minimum expected frequency is 2.24. 
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AP4. Table 47: Relationship between taking allergies drugs [diphenhydramine, cetirizine, 
loratidine] during pregnancy and the thought of how safe [OTC, Herbal, Vitamin] are during 
pregnancy.   
Allergies 
[diphenhydram
ine, cetirizine, 
loratidine] 
How safe do you think [OTC, Herbal, Vitamin]  are during 
pregnancy? 
Total 
Safe, but I would 
talk to a healthcare 
professional before 
using 
Safe, but I would 
check with 
resources, such as 
friends or the 
Internet, before 
using 
Unsafe, I would not 
use these during 
pregnancy. 
Frequency (%) Frequency (%) Frequency (%) Frequency (%) 
Yes  3 1.5 0 0.0 1 0.6 4 1.0 
No 202 98.5 25 100.0 160 99.4 387 99.0 
Total 205 100.0 25 100.0 161 100.0 391 100.0 
 
Chi-Square Tests 
 Value Df Asymp. Sig. (2-sided) 
Pearson Chi-Square .908
a
 2 .635 
Likelihood Ratio 1.159 2 .560 
Linear-by-Linear Association .655 1 .418 
N of Valid Cases 391   
a. 3 cells (50.0%) have expected frequency less than 5. The minimum expected frequency is .26. 
 
 
AP4. Table 48: Relationship between taking Over-the-counter vitamins (vitamin D, calcium, 
prenatal vitamin, folic acid) during pregnancy and the thought of how safe [OTC, Herbal, 
Vitamin] are during pregnancy.   
Over-the-
counter 
vitamins 
(Vitamin 
D, 
Calcium, 
Prenatal 
Vitamin, 
folic acid) 
How safe do you think [OTC, Herbal, Vitamin]  are during 
pregnancy? 
Total 
Safe, but I would talk 
to a healthcare 
professional before 
using 
Safe, but I would 
check with 
resources, such as 
friends or the 
Internet, before 
using 
Unsafe, I would not 
use these during 
pregnancy. 
Frequency (%) Frequency (%) Frequency (%) Frequency (%) 
Yes  197 96.1 25 100.0 161 100.0 383 98.0 
No 8 3.9 0 0.0 0 0.0 8 2.0 
Total 205 100.0 25 100.0 161 100.0 391 100.0 
  
Chi-Square Tests 
 Value Df Asymp. Sig. (2-sided) 
Pearson Chi-Square 7.410
a
 2 .025 
Likelihood Ratio 10.483 2 .005 
Linear-by-Linear Association 6.948 1 .008 
N of Valid Cases 391   
a. 3 cells (50.0%) have expected frequency less than 5. The minimum expected frequency is .51. 
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Appendix 5 : Distribution Tables and Figures  
 
 
AP5. Table 1 . Distribution of body max index among respondents.  
BMI Frequency % Valid Percent Cumulative Percent 
<18.5 2 0.4 0.4 0.4 
18.5-24.9 193 34.8 34.8 35.1 
25-29.9 356 64.1 64.1 99.3 
>30 4 0.7 0.7 100.0 
Total 555 100.0 100.0  
  
AP5 .Figure 1: The percentage of Body Max Index among respondents 
 
 72 
AP 5. Table 2.  Distribution of residence among respondents.   
Residence Frequency % Valid Percent Cumulative Percent 
Ramallah 238 42.9 42.9 42.9 
Nablus 125 22.5 22.5 65.4 
Hebron 192 34.6 34.6 100.0 
Total 555 100.0 100.0  
 
 
 
  
 
AP5. Figure 2: The percentage of Residence among respondents.  
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AP5. Table 3: Distribution of highest level of education among respondents.   
Highest Level of Education 
Frequency % Valid Percent 
Cumulative 
Percent 
Less than high school 171 30.8 30.8 30.8 
High school diploma 106 19.1 19.1 49.9 
college or technical degree 136 24.5 24.5 74.4 
4-year college degree 109 19.6 19.6 94.1 
Professional or graduate degree 33 5.9 5.9 100.0 
Total 555 100.0 100.0  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
AP5. Figure 3: The percentage of Higher Level  Education among respondents.  
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AP5. Table 4: Distribution of current pregnancy trimester among respondents.   
 
Current Pregnancy 
Trimester Frequency % Valid Percent Cumulative Percent 
(0-3 months) 54 9.7 9.7 9.7 
(4-6 months) 196 35.3 35.3 45.0 
(7-9 months) 305 55.0 55.0 100.0 
Total 555 100.0 100.0  
 
 
 
 
 
 
 
 
 
 
AP5. Figure 4: The percentage of Current Pregnancy Trimester among respondents.  
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AP5. Table 5: Distribution of miscarriage among respondents. 
Miscarriage Frequency % Valid Percent Cumulative Percent 
Yes 194 35.0 35.0 35.0 
No 361 65.0 65.0 100.0 
Total 555 100.0 100.0  
 
 
 
 
 
 
 
 
 
 
 
 
 
AP5. Figure 5: The percentage of miscarriage among respondents.  
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AP5.Table 6: Distribution of prematurity/mortality among respondents. 
Prematurity/ 
mortality Frequency % Valid Percent Cumulative Percent 
Yes 132 23.8 23.8 23.8 
No 423 76.2 76.2 100.0 
Total 555 100.0 100.0  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 AP5. Figure 6: The percentage of Prematurity/ Mortality among respondents.  
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AP5. Table 7: Distribution of Nullparity  among respondents. 
Nullparity Frequency % Valid Percent Cumulative Percent 
Yes 58 10.5 10.5 10.5 
No 497 89.5 89.5 100.0 
Total 555 100.0 100.0  
 
 
 
 
 
 
 
 
 
 
 
AP5. Figure 7: The percentage of nullparity among respondents. 
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AP5. Table 8: Distribution of gravidity  among respondents. 
Gravidity Frequency % Valid Percent Cumulative Percent 
1 155 27.9 27.9 27.9 
2 106 19.1 19.1 47.0 
3 or more 294 53.0 53.0 100.0 
Total 555 100.0 100.0  
 
 
 
 
 
 
  
 
  
AP5. Figure 8: The percentage of gravidity among respondents. 
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AP5. Table 9: Distribution of Parity among respondents. 
Parity Frequency % Valid Percent Cumulative Percent 
0 81 14.6 14.6 14.6 
1 91 16.4 16.4 31.0 
2 139 25.0 25.0 56.0 
3 100 18.0 18.0 74.1 
4 or more 144 25.9 25.9 100.0 
Total 555 100.0 100.0  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AP5. Figure 9: The percentage of parity among respondents. 
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AP5. Table 10: Distribution of Smokers during pregnancy 
among respondents. 
Smoking during 
pregnancy Frequency % Valid Percent Cumulative Percent 
Yes 197 35.5 35.5 35.5 
No 358 64.5 64.5 100.0 
Total 555 100.0 100.0  
  
AP5. Figure 10: The percentage of smoking during pregnancy among respondents.  
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AP5. Table 11:  Distribution of alcohol consumers during pregnancy 
among respondents. 
Alcohol 
consumption 
during pregnancy Frequency % Valid Percent Cumulative Percent 
Yes 6 1.1 1.1 1.1 
No 549 98.9 98.9 100.0 
Total 555 100.0 100.0  
  
AP5. Figure 11: The percentage of alcohol consumers during pregnancy among 
respondents.  
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AP5. Table 12: distribution of general practitioner visits among 
respondents.  
General 
Practitioner Visits Frequency % Valid Percent Cumulative Percent 
0 29 5.2 5.2 5.2 
1 53 9.5 9.5 14.8 
2 145 26.1 26.1 40.9 
3 or more 328 59.1 59.1 100.0 
Total 555 100.0 100.0  
  
AP5. Figure 12: The percentage of numbers of general practitioner visits during 
pregnancy among respondents.  
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AP5. Table 13: Distribution of extra midwife visits during pregnancy 
among respondents. 
Extra midwife 
visits Frequency Percent Valid Percent Cumulative Percent 
0 360 64.9 64.9 64.9 
1 51 9.2 9.2 74.1 
2 22 4.0 4.0 78.0 
4 122 22.0 22.0 100.0 
Total 555 100.0 100.0  
  
AP5. Figure 13: The percentage of numbers of extra midwife visits during 
pregnancy among respondents.  
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AP5. Table 14: Distribution of comorbidity (e.g. cardiac disease, lung disease 
and other chronic diseases) among respondents. 
Comorbidity Frequency Percent Valid Percent Cumulative Percent 
Yes 71 12.8 12.8 12.8 
No 484 87.2 87.2 100.0 
Total 555 100.0 100.0  
 
 
 
AP5. Figure 14: The percentage of comorbidity among respondents.  
 85 
AP5. Table 15: Distribution of take prescribed drugs by healthcare professionals   
Have any healthcare 
professional prescribed 
you any drug 
(Prescription drugs) 
Frequency % Valid Percent Cumulative Percent 
Yes 251 45.2 45.2 45.2 
No 304 54.8 54.8 100.0 
Total 555 100.0 100.0  
 
 
 
AP5. Figure 15: The percentage of taken prescribed drugs by healthcare 
professionals among respondents.  
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 AP5. Table 16 :  If yes what is/are they 
 Frequency % Valid Percent Cumulative Percent 
1 180 71.7 71.7 71.7 
2 71 28.3 28.3 100.0 
Total 251 100.0 100.0  
  
AP5. Figure 16: The percentage of If yes what she is/ are they among 
respondents.  
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AP5. Table 17: Taken paracetamol, ibuprofen or aspirin during your 
current pregnancy among respondents. 
Paracetamol, 
ibuprofen or 
aspirin 
Frequency Percent Valid Percent Cumulative Percent 
Yes 183 46.8 46.8 46.8 
No 208 53.2 53.2 100.0 
Total 391 100.0 100.0  
 
  
AP5.  Figure  17 The percentage of taken paracetamol, ibuprofen or aspirin during 
current pregnancy among respondents.  
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AP5. Table 18: Taken Cold, cough, or sore throat drugs [nasal sprays, 
Lozenges, pseudoephedrine] during your current pregnancy among 
respondents. 
 
Cold, cough, or sore 
throat drugs [nasal 
sprays, Lozenges, 
pseudoephedrine] 
Frequency % Valid Percent Cumulative Percent 
Yes 9 2.3 2.3 2.3 
No 382 97.7 97.7 100.0 
Total 391 100.0 100.0  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
AP5. Figure 18: The percentage of taken cold, cough, or sore throat drugs [nasal 
sprays, Lozenges, pseudoephedrine] during current pregnancy among respondents.  
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AP5.  Table 19: Taken heartburn or acid reflux [antacid, famotidine, ranitidine, 
omeprazole] during your current pregnancy among respondents. 
 
Heartburn or acid 
reflux [antacid, 
famotidine, ranitidine, 
omeprazole] 
Frequency % Valid Percent Cumulative Percent 
Yes 382 97.7 97.7 97.7 
No 9 2.3 2.3 100.0 
Total 391 100.0 100.0  
 
  
AP5.  Figure 19: The percentage of taken heartburn or acid reflux [antacid, 
famotidine, ranitidine, omeprazole] during current pregnancy among 
respondents.  
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AP5. Table 20: Taken constipation, diarrhea, or upset stomach [laxidin, 
lopremide] during your current pregnancy among respondents. 
 
Constipation, diarrhea, 
or upset stomach 
[laxidin, lopremide] 
Frequency % Valid Percent Cumulative Percent 
Yes 35 9.0 9.0 9.0 
No 356 91.0 91.0 100.0 
Total 391 100.0 100.0  
 
  AP5. Figure 20: The percentage of taken constipation, diarrhea, or upset 
stomach [laxidin, lopremide] during current pregnancy among respondents.  
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AP5. Table 21: Taken allergies [diphenhydramine, cetirizine, loratidine] during 
your current pregnancy among respondents. 
 
Allergies 
[diphenhydramine, 
cetirizine, loratidine] 
Frequency % Valid Percent Cumulative Percent 
Yes 4 1.0 1.0 1.0 
No 387 99.0 99.0 100.0 
Total 391 100.0 100.0  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
AP5. Figure 21: The percentage of taken allergies [diphenhydramine, 
cetirizine, loratidine] during current pregnancy among respondents.  
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AP5. Table 22: Taken over-the-counter vitamins (vitamin D, calcium, prenatal 
Vitamin, folic acid) during your current pregnancy among respondents. 
 
Over-the-counter vitamins 
(Vitamin D, Calcium, 
Prenatal Vitamin, folic 
acid 
Frequency % Valid Percent Cumulative Percent 
Yes 383 98.0 98.0 98.0 
No 8 2.0 2.0 100.0 
Total 391 100.0 100.0  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
AP5.  Figure 22: The percentage of over-the-counter vitamins (vitamin D, 
calcium, prenatal Vitamin, folic acid) during current pregnancy among 
respondents.  
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AP5. Table 23: Distribution of OTC medications recommenders. 
If you have used OTC 
medicines while 
pregnant, who 
recommended them? 
Frequency % Valid Percent Cumulative Percent 
Physician/Doctor 323 82.6 82.6 82.6 
Midwife/Nurse 48 12.3 12.3 94.9 
Pharmacist 4 1.0 1.0 95.9 
I chose on my own 16 4.1 4.1 100.0 
Total 391 100.0 100.0  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AP5. Figure 23: The percentage of OTC medication recommenders for 
respondents.  
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AP5. Table 24: Distribution of OTC medications information source for use 
OTC medications during pregnancy. 
Where did you or have you gotten 
your information about the use of 
over-the-counter medications 
during your pregnancy? 
Frequency % 
Valid 
Percent 
Cumulative 
Percent 
Physician 36 9.2 9.2 9.2 
Midwife/nurse 3 .8 .8 10.0 
Pharmacist 325 83.1 83.1 93.1 
Internet, Family and friends 27 6.9 6.9 100.0 
Total 391 100.0 100.0  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AP5. Figure 24: The percentage of the source of information about OTC 
medication use during pregnancy for respondents.  
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AP5. Table 25: The thought of the safety of [OTC, Herbal, Vitamin] use during 
pregnancy   
How safe do you think [OTC, Herbal, 
Vitamin] are during pregnancy? Frequency % 
Valid 
Percent 
Cumulative 
Percent 
Very safe, I don't need to talk to a healthcare 
professional before using. 
3 0.5 0.5 0.5 
Safe, but I would talk to a healthcare 
professional before using. 
361 65.0 65.0 65.6 
Safe, but I would check with resources, such 
as friends or the Internet, before using 
27 4.9 4.9 70.5 
Unsafe, I would not use these during 
pregnancy. 
164 29.5 29.5 100.0 
Total 555 100.0 100.0  
 
 
  
Figure 52: The percentage of the thought of safety for OTC medication use during 
pregnancy among respondents.  
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AP5. Table 26: The relationship between miscarriage and OTC medications intake during 
pregnancy.  
OTC medication N 
Previous Miscarriage 
Df P (Chi 2) 
Yes % No % 
Paracetamol, Ibuprofen and 
Aspirin 
183 67 42.7 116 49.6 1 0.18 
Cold, cough, or sore throat [nasal sprays, 
Lozenges, pseudoephedrine] 9 3 1.9 6 2.6  0.67 
Heartburn or acid reflux [antacid, 
famotidine, ranitidine, omeprazole] 382 154 98.1 228 97.4  0.67 
Constipation, diarrhea, or upset stomach 
[laxidin, lopremide] 35 6 3.8 29 12.4  0.004 
Allergies [diphenhydramine, cetirizine, 
loratidine] 4 1 0.6 3 1.3  0.53 
Over-the-counter vitamins (Vitamin D, 
Calcium, Prenatal Vitamin, folic acid) 383 154 98.1 229 97.9  0.87 
 
AP5. Table 27: The relationship between nullparity and OTC medications intake 
during pregnancy. 
OTC medication N 
Nullparity 
Df P (Chi 2) 
Yes % No % 
Paracetamol, Ibuprofen and 
Aspirin 
183 32 55.2 151 45.3 1 0.16 
Cold, cough, or sore throat [nasal sprays, 
Lozenges, pseudoephedrine] 
9 2 3.4 7 2.1  0.53 
Heartburn or acid reflux [antacid, 
famotidine, ranitidine, omeprazole] 
382 55 94.8 327 98.2  0.11 
Constipation, diarrhea, or upset stomach 
[laxidin, lopremide] 
35 5 8.6 30 9.0  0.92 
Allergies [diphenhydramine, cetirizine, 
loratidine] 
4 0 0.0 4 1.2  0.40 
Over-the-counter vitamins (Vitamin D, 
Calcium, Prenatal Vitamin, folic acid) 
383 56 96.6 327 98.2  0.41 
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AP5. Table 28: The relationship between prematurity or mortality and OTC 
medications intake during pregnancy.  
OTC medication  N 
Prematurity/mortality 
Df P (Chi 2) 
Yes % No % 
Paracetamol, Ibuprofen and 
Aspirin 
183 10 8.1 173 64.6 1 0.00 
Cold, cough, or sore throat [nasal sprays, 
Lozenges, pseudoephedrine] 
9 0 0.0 9 3.4  0.04 
Heartburn or acid reflux [antacid, 
famotidine, ranitidine, omeprazole] 
382 114 92.7 268 100.0  0.00 
Constipation, diarrhea, or upset stomach 
[laxidin, lopremide] 
35 0 0.0 35 13.1  0.00 
Allergies [diphenhydramine, cetirizine, 
loratidine] 
4 4 3.3 0 0.0  0.003 
Over-the-counter vitamins (Vitamin D, 
Calcium, Prenatal Vitamin, folic acid) 
383 123 100.0 260 97.0  0.053 
 
 
AP5. Table 29: The relationship between gravidity and OTC medications intake during 
pregnancy. 
OTC medication  N Gravidity Df P (Chi 2) 
  1 % 2 % 3 %   
Paracetamol, Ibuprofen and 
Aspirin 
183 54 88.5 35 33.0 94 42.0 2 0.00 
Cold, cough, or sore throat [nasal 
sprays, Lozenges, 
pseudoephedrine] 
9 5 8.2 0 0.0 4 1.8  0.002 
Heartburn or acid reflux [antacid, 
famotidine, ranitidine, 
omeprazole] 
382 59 96.7 104 98.1 219 97.8  0.84 
Constipation, diarrhea, or upset 
stomach [laxidin, lopremide] 
35 18 29.5 0 0.0 17 7.6  0.00 
Allergies [diphenhydramine, 
cetirizine, loratidine] 
4 0 0.0 2 1.9 2 0.9  0.49 
Over-the-counter vitamins 
(Vitamin D, Calcium, Prenatal 
Vitamin, folic acid) 
383 56 91.8 106 100.0 221 98.7  .001 
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AP5. Tab 30: The relationship of the thought of safety of OTC drugs and OTC taken during pregnancy. 
OTC medication N 
How safe do you think [OTC, Herbal, Vitamin] are during pregnancy? 
Df 
P (Chi 
2) 
Safe, but I 
would talk to 
a healthcare 
professional 
before using 
% 
Safe, but I 
would check 
with 
resources, 
such as 
friends or the 
Internet, 
before using 
% 
Unsafe, I 
would not 
use these 
during 
pregnancy. 
% 
Paracetamol, Ibuprofen and 
Aspirin 
183 112 54.6 11 44.0 60 37.3 2 0.004 
Cold, cough, or sore throat 
[nasal sprays, Lozenges, 
pseudoephedrine] 
9 9 4.4 0 0.0 0 0.0  0.015 
Heartburn or acid reflux 
[antacid, famotidine, 
ranitidine, omeprazole] 
382 198 96.6 25 100.0 159 98.8  0.28 
Constipation, diarrhea, or 
upset stomach [laxidin, 
lopremide] 
35 35 17.1 0 0.0 0 0.0  0.00 
Allergies [diphenhydramine, 
cetirizine, loratidine] 
4 3 1.5 0 0.0 1 0.6  0.64 
Over-the-counter vitamins 
(Vitamin D, Calcium, 
Prenatal Vitamin, folic acid) 
383 197 96.1 25 100.0 161 100.0  0.025 
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